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INTRODUCTION 
During the last 20 years ocular findings in sickle cell patients have been well documented. 
Most clinical studies were performed in Jamaica and in Chicago, USA. With the exception 
of the children's cohort in Jamaica, studies have generally been limited to selected samples 
of only small portions of the sickling population, simply because of the large number of 
sickle cell patients in those countries. 
Given Curacao's restricted area and relatively well-organized infrastructure, we saw 
an opportunity to study ocular involvement in the majority of the island's sickling patients. 
This would enable us to establish prevalence of visual loss in an entire island population, as 
well as to determine, retrospectively, the age of onset of complications. We hoped to 
contribute to public health on Curacao by identifying patients whose degree of ocular 
involvement was potentially sight-threatening, and who might eventually benefit from the 
introduction of a treatment modality. Moreover, we could focus prospectively on several 
related areas of interest. For these reasons, I undertook a project that involved the 
recruitment and examination of all traceable sickle cell patients on Curacao from 
November 1986 through June 1988. 
In Part I of this thesis, the pathophysiology and clinical course of various types of 
sickle cell disease will be discussed. Part II consists of a discussion of previously published 
data on ocular involvement in sickle cell disease, grouped according to the anatomical area 
involved, such as the conjunctiva, trabeculum, iris, vitreous, retina and choroid. Listed 
herein are reports concerning treatment of sickle cell retinopathy and its complications, in 
addition to reports of severe visual loss due to sickle cell disease. Part III relates our own 
findings from Curacao, which are grouped in much the same manner as in Part II, and 
compared with published data where relevant. Part IV contains four studies based on 
survey material, but which have no precise published counterpart. The summary is in 
Dutch, English, and Papiamentu. 
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PARTI 
PATHOGENESIS OF SICKLE CELL DISEASE 
INTRODUCTION 
Upon deoxygenation erythrocytes containing the abnormal hemoglobin S can assume a 
sickled shape. This phenomenon was observed by Herrick as early as 1910. The ocular 
findings in patients with sickling red cells are the subject of this thesis. 
In postembryonic life, hemoglobin (Hb) F, Hb A and Hb A2 are regarded as the 
normal hemoglobins. Each hemoglobin molecule is a tetramer, composed of one pair of 
alpha-chains and one pair of non alpha-chains: gamma in Hb F, beta in Hb A, delta in Hb 
A * 
In 1949, Pauling observed an abnormally-moving hemoglobin fraction on 
hemoglobin electrophoresis of hemolyzed sickling red cells; in 1956, Ingram was able to 
identify the amino acid substitution on the beta-chain in hemoblobin S. Since that time, 
over 500 abnormal hemoglobins have been identified, of which Hb С and Hb E are the 
most wide-spread hemoglobins associated with clinical symptoms (Wrightstone, 1984). 
The familial, autosomal, co-dominant nature of Hb SS disease and the difference 
between heterozygous ("sickle cell trait") and homozygous disease were already known in 
1932 (Diggs). 
Another set of hemoglobin disorders are the thalassemias, which can coexist in the 
same patient. Although alpha- and beta- (or delta- or gamma-) chains in thalassemia are 
qualitatively normal, their rate of synthesis is, in varying degrees, decreased by the 
alteration of genes coding for these chains. In alpha-thallassemia (four degrees of severity 
are now in clinical use; Higgs et al., 1983), alpha-chain synthesis is decreased; in beta-
thalassemia (three degrees of severity; Weatherall et al., 1981), there is a decrease in beta-
chains. 
PATHOPHYSIOLOGY 
Under conditions of hypoxia, acidosis and hyperosmolarity, deoxygenated Hb S forms rigid 
polymers, thus decreasing red cell pliability and transforming an erythrocyte into the 
sickled shape (Eaton et al., 1987; Noguchi et al., 1981). These changes in the red cell lead 
to hemolysis, as well as to an increase in blood viscosity, that affects rheology in the 
microcirculation. Since vaso-occlusion is thought to be the principle cause of the 
conjunctival, iridic, retinal and choroidal lesions in sickle cell patients, its pathogenesis will 
be discussed. 
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RHEOLOGY 
Viscosity of blood is largely determined by its formed elements (most prevalently, the 
erythrocytes (Home, 1981). Their quantity (as expressed in numbers or hemoglobin 
concentration) and their quality (as expressed in hematocrit [Ht], mean cell volume 
[MCV], mean cell hemoglobin concentration [MCHC], type of hemoglobin they contain, 
the rate of sickling on deoxygenation or pH changes) are consequently important factors in 
blood viscosity. Whole blood viscosity is influenced by vessel diameter and flow velocity 
(shear rate; KJug et al., 1974). The precapillary arteriole (smallest diameter, but relatively 
rapid flow), capillaries (slowest flow, but high pressure gradient) and postcapillary venules 
(larger diameter, slow flow, minimal pressure gradient) are the sites where flow is most 
jeopardized by stiff, abnormal red cells. 
In plasma, dissolved elements, particularly proteins such as fibrinogen, globulins and 
"acute phase proteins", can increase viscosity in certain disease states (e.g. infection). It 
has been thought (Home et al., 1981; Embury, 1985) that single cell characteristics are the 
most important factor in the smallest vessels, whereas quantitive indices (e.g. packed cell 
volume, hemoglobin concentration) are of greater significance in slightly larger vessels. 
ERYTHROCYTES 
Unfortunately, deoxygenated Hb S molecules have the potential to form reversibly long 
aggregates within the erythrocyte, a process known as gelation (Noguchi et al., 1981). The 
rate at which gelation occurs is influenced by pH, temperature and most particularly by the 
concentration of both desoxy- and oxy-hemoglobin, and is time-dependant in a manner 
suggestive of a crystallization process (Eaton et al., 1976). The delay time is that period 
during which no visible reaction is observed in hemoglobin solutions before gelation 
rapidly proceeds in a time equal to or less than the delay time. 
In a deoxygenated or acidic environment, Hb SS and Hb SC red cells show an 
abnormal loss of potassium and water, thus increasing MCHC (Brugnara et al., 1986). 
Using a micropipette suction technique, Evans et al. (1983) showed the major influence of 
MCHC on static and dynamic rigidity of erythrocytes in vitro . 
After repetitive cycles of sickling/unsickling, some membrane is lost (Fabry et al., 
1982). The irreversibly sickled cell (ISC) is the fraction of densest red cells and appears to 
represent the end-stage of cells most prone to sickling/unsickling episodes, possibly due to 
their low Hb F content. However, Kaul et al., (1982) isolated another red cell fraction with 
high viscosity in vitro and occlusive affinity in isolated vasculature (rat meso-appendix). He 
described this finding as "dense (high MCHC) discocytes", which change shape very little 
during oxygenation and thus show no sickle morphology. Even in a highly oxygenated 
state, they were found to contain polymer, suggesting to Noguchi and collegues (1981) that 
rhéologie problems can also occur on the arterial side of the circulation; the precapillary 
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arteriole, as the site of major constriction to flow, is implicated. These cells and the ISC 
are selectively trapped in the Baez preparation on deoxygenation (Kaul et al., 1986), thus 
offering an explanation for the clinical observation of dense cell disappearance during 
crises (Fabry et al., 1984). This may indicate that not ISCs alone, (or the F4 fraction alone, 
Billet et al., 1986), but rather the combination of ISCs and dense discocytes should be 
tested in relation to clinical severity. In the fraction of denser erythrocytes on 
ultracentrifugation the delay time can be the same as capillary transit time (1 sec), which 
led Eaton et al. (1976) to their kinetic hypothesis, that stated: "when delay times are 
shortened enough or the capillary transit times lengthened enough, intracapillary sickling 
occurs, called crisis". 
The generally less abnormal hematologic indices (lower hemolysis, higher lib) and 
possibly milder clinical courses in patients with Hb S combined with alpha-thalassemia 
(Higgs et al., 1982), in patients doubly heterozygous for Hb S and beta-thalassemia, in iron 
deficiency (Castro et al. 1983) and in Hb S with heterocellular persistent fetal hemoglobin 
or beneficial haplotype (Powars et al., 1984) appear to result primarily from a decreased 
Hb S-MCHC (BE Serjeant et al., 1983). In alpha-thalassemia, some vaso-occlusive events 
benefit, but others do not. The advantageous decrease of MCHC is apparently offset by 
the rheologically disadvantageous higher packed cell volume. The diameter of the involved 
vessel may be a factor in this variability (Embury, 1985). Though the low hematocrit in Hb 
SS can be regarded as an adaptive mechanism (Milner, 1974; Home, 1981), the severity of 
the anemia may be an important determinant of the ultimate clinical consequence of sickle 
cell anemia: life expectancy (Embury, 1985). 
THROMBOSIS 
Although a higher than normal concentration of coagulation factors may arise within a 
syncytium of sludged erythrocytes, there appears to be no evidence that thrombosis is the 
initiating event in vaso-occlusion (Rickles et al., 1974). Thrombosis could be a secondary 
phenomenon, after sickled cells have damaged the vessel's endothelium, mechanically or by 
hypoxia, baring collagen or releasing tissue-factor as inductors of the intrinsic and extrinsic 
pathways of coagulation. Decreased ability of the reticulo-endothelial system (RES)(organ 
failure in spleen and liver) to remove activated coagulation factors may accelerate this 
process. In sickle cell patients during crisis, a hyperthrombocythemia is also present 
(Kenny et al., 1980). 
VESSELS 
Hebbel et al. (1980) and Mohandas et al. (1984) reported an abnormally high adherence 
of Hb SS erythrocytes to cultured human endothelial cells and found a positive correlation 
with the number of vaso-occlusive episodes in the patients they studied.No such correlation 
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was found with other, more well-known possible influencing factors, such as red cell 
indices, reticulocyte count, Hb F or irreversibly sickled cells. 
Vasoregulative neuronal mechanisms may influence transit times in the capillary 
bed by formation of arteriovenous shunts (Manfredi et al., 1960). Interestingly, the use of 
laser-Doppler velocimetry revealed a possibly adaptive mechanism in Hb SS patients on a 
micro-vascular level (Rodgers et al., 1984). This mechanism was marked by periodic 
capillary flow, possibly to overcome capillary occlusion, since increasing perfusion pressure 
proved to be effective in disobstructing plugged capillaries in isolated meso-appendix (Klug 
et al., 1972). 
SUMMARY 
The concept of a "vicious circle of erythrostasis" could be updated as follows: dense cells 
and increased red cell adhesion to endothelium, slow down blood flow and increase transit 
time, metabolic acidosis and deoxygenation, which results in intracellular gelation. This 
leads to further loss of pliability, sickling and vaso-occlusion, either in the capillaries (dense 
discocytes), in the precapillary arterioles (irreversibly sickled cells), or in the postcapillary 
venules (Klug 1977, Lacelle 1977). These plugs may jeopardize the integrity of the 
endothelium and initiate thrombosis (Stemerman et al., 1972,). Abnormally high levels of 
coagulation factors (defective RES function) or high fibrinogen (such as results from 
infection, dehydration and fever), may in turn increase both blood viscosity and the rate of 
thrombosis (Padilia 1973). Microcirculatory adaptive mechanisms may counteract these 
vaso-occlusive tendencies (Rodgers et al., 1984). 
CLINICAL COURSE OF SICKLING DISORDERS 
The term "sickle cell disease" covers a group of conditions whose pathology may be 
attributed to the presence of Hb S. Hb AS is therefore not included in this definition 
(Serjeant, 1985a). 
HB SS 
The hemoglobinopathy SS (homozygous Hb S disease, or sickle cell anemia) is 
characterized by a severe hemolytic anemia, periodic attacks ("crises") of pain in the bones, 
muscles and viscera due to vaso-occlusion in the microcirculation and a heightened 
susceptibility to infection. An aplastic crisis refers to failure of the bone marrow. 
Cerebrovascular accidents occurring at a young age are another dramatic manifestation 
(Powars et al., 1978). 
Life expectancy is greatly reduced. During childhood, sickle cell crises primarily 
determine the clinical picture; in adults, however, the frequency of crises decreases, but 
organ failure (such as chronic renal disease) becomes more common (Serjeant, 1985b). 
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The clinical course of Hb SS is influenced by many factors, including climate, nutrition 
(folate deficiency), exposure to infection (parvovirus, pneumococcus), and the Theological 
factors described above. 
HB SC 
The hemoglobinopathy SC (double heterozygotes for Hb S and Hb С) is a generally mild 
condition with nearly normal haemoglobin levels and a modest decrease in red cell survival 
(Serjeant, 1985c). Some patients are almost asymptomatic and the diagnosis is frequently 
made during screening procedures. 
The same spectrum of pathology as is evident in Hb SS disease occurs; however, 
complications that arise are generally less frequent and less severe. This holds true for 
pulmonary lesions, aseptic necrosis of the femoral head, and obstetrical pathology 
(Charache et al., 1980; Milner et al., 1980). Interestingly, however, there is a much higher 
incidence of proliferative retinopathy in Hb SC disease (Welch et al., 1966; Condon et al., 
1972b; this thesis). The normal hemoglobin concentration and hematocrit, in combination 
with the sickling potential of the Hb SC erythrocyte can jeopardize rheology considerably 
under certain conditions; apparently these conditions exist in the eye. 
HB S-BETA-THALASSEMIA 
Heterozygosity for Hb S and beta-thalassemia is termed Hb S-beta-thalassemia. Where 
the thalassemic gene coding for beta-chains does not function at all, the socalled Hb S-
beta-O-thalassemia resembles Hb SS disease clinically, hematologically and 
electrophoretically. As more Hb A (from 15 to 30 %) is being synthesized in other 
variants, a moderately severe to mild clinical course results. Hb Aj is elevated in these 
patients. 
HBSF 
Although a higher than normal percentage of Hb F occurs in sickle cell patients in various 
ways, the term Hb SF is used here for the hereditary persistence of fetal hemoglobin, in 
which at least 15% Hb F is found pancellularly. In patients with this distribution and these 
percentages of Hb F, Hb SF disease tends to run a benign course (Serjeant, 1985d). 
HB AS 
Sickle cell trait (heterozygous Hb S carrier) is essentially an asymptomatic state, occurring 
in 8-12% of the Negroid population in the USA. A much higher frequency has been found 
in some parts of Africa, Saudi Arabia and India, and a low prevalence in the 
Mediterranean region (Serjeant, 1985e). Only under extreme circumstances (e.g. flying in 
unpressurized aircraft; Smith et al., 1955) painful crises have been reported to occur. A 
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mild nephropathy due to sickling in the renal medulla, however, will develop in all Hb AS 
patients (Sears, 1978). 
The significance of any other reported association remains speculative, since either 
a firm diagnosis of sickle cell trait only has been lacking or other causes have not been 
excluded. In addition, an inevitable bias tends to result from the overreporting of any 
complication where a pathogenetically interesting finding as Hb AS occurs (Serjeant, 
1985f). 
HB AC 
Hb С trait (heterozygous Hb С carrier) is as asymptomatic as the sickle cell trait and is, in 
fact, not a sickling disorder. Sickling occurs only in erythrocytes containing Hb S as well 
(as in Hb SC), but at a considerably higher rate than in Hb AS erythrocytes. Hb С has 
been shown to induce an abnormally high mean cell hemoglobin concentration in Hb SC 
cells, which contain 70% Hb S (Brugnara et al., 1986). As a contrast, in sickle cell trait the 
erytrocytes contain usually less than 50% Hb S. Despite the absence of sickling, the red 
cells in Hb AC or Hb CC patients are less pliable than those in Hb AA or Hb AS cases. 
DIAGNOSIS 
A discussion of the diagnosis of the different sickle cell syndromes is beyond the scope of 
this thesis. Generally, clinical assessment and morphology on blood smears may alert one 
to the possibility of sickling disorders. To confirm the diagnosis, it is necessary to perform 
the tests listed below, in combination with red cell indices and wherever indicated, family 
studies. 
CONFIRMATORY TESTS FOR 
Sickle 
VARIOUS 
cell test 
Hb SS + 
Hb SC + 
Hb SS-alpha-thal * 
Hb S-beta-thal * 
Hb SF + 
Hb AS + 
Hb AC 
COMMON SICKLE CELL DISORDERS 
Alkaline 
Electro­
phoresis 
+ 
+ 
+ 
+ 
+ 
+ 
-f 
Quantification Gene 
of Hb AZ Hb F mapping 
+ -f 
+ 
+ + 
Table 1 
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THERAPY 
As the majority of Hb SS (or Hb SC) patients have parents with sickle trait only, who have 
consequently little insight in the homozogous disease, preventive genetic counseling has not 
proven very effective. Prenatal diagnosis with the option of abortion is technically and 
ethically a controversial issue. 
Given the greatly increased knowledge of the pathophysiology of sickling, many 
theoretically sound therapies have been applied in an effort to: 
- decrease Hb S interaction in gel (alkali, urea, nitrogen mustards). 
- decrease red cell desoxygenated Hb S concentration (MCHC) by plasma hypo-osmolarity, 
by shifting the hemoglobin dissociation curve, or by stimulating Hb F production. 
- lower blood viscosity (dextran). 
- modify the red cell membrane (cietidil). 
Other approaches include the use of vasodilators, anti-coagulants, oxygen and even 
incidentally bone-marrow transplantation (Johnson et al., 1984). Dean et al. (1978) and 
Schechter et al. (1987) provide reviews covering this fascinating field. Although some 
compounds showed promising results in studies, no drug has yet emerged as the drag of 
choice. 
Although the life expectancy for Hb SS patients has increased over the last decades 
in more affluent countries, this is probably due to improvements in general nutritional and 
living standards, supportive care and the treatment or prevention of infections, not to a 
specific therapy. The mainstay of treatment remains supportive and symptomatic, ranging 
from rehydration, sedation and analgesia to early treatment of infections and blood 
transfusions (Johnson, 1985). Prevention of infections (long-term peniciline in Hb SS 
children, Gaston et al., 1986) has proven to be effective. Possibly the most important 
function of sickle cell clinics is to help patients to avoid crises-provoking circumstances and 
to cope with their symptoms by regular counseling and education. 
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PARTII 
CHAPTER 1 
CONJUNCTIVA 
INTRODUCTION 
In sickle cell patients, we can observe apparently isolated segments of conjunctival vessels. 
Such segments, which are sometimes comma-shaped and occasionnaly straighter have been 
described by Paton as "the conjunctival sign" (1962). The conjunctiva may be icteric, 
particularly during a crisis in which the hemolytic rate increases. 
REPORTS 
Compiling the pertinent reports, the conjunctival sign was present in 89% of Hb SS 
patients, in 62% of Hb SC patients, and in 77% of Hb S-beta-thalassemia patients. It was 
not present in persons with either Hb AA or Hb AS (Table 2). 
REPORTED 
Author 
Kniseley 
CONJUNCTIVAL ABNORMALITIES 
De Quevedo 
Goodnan 
Lieb et al 
Paton 
Fink 
Corner et 
Goldberg 
Condon 
Total 
a 
Tear 
1947 
1952 
1957 
.1961 
1962 
1962 
I.'64 
1971 
1972 
1979 
Hb 
type 
SS 
SS 
SS 
sc 
ss 
sc 
ss 
sc 
AS 
AA 
SS 
sc 
AA 
SS 
SC 
AA/AS 
Nunber Conjunctival 
pat ients vesse 
51 
9 
56 
15 
20 
75 
86 
15 
112 
33 
13 
50 
S-B-thal 14 
SS 
S-B-th 
76 
3l 50 
SO Arab 
SS 
SC 
302 
52 
S-B-thal 64 
AA/AS 257 
abnormalities 
sludg 
saccu 
ng 
ar 
of blood 
or sausage-
like dilatations; 
cular 
contna-
mie 
sac 
roaneurysms. 
shaped i sol 
segments 
ated 
Table 2 
НшЬег of 
patients with 
conjunctival 
sign 
5 
1 
2 
22 
4 
54 
12 
-
-
82 
12 
0 
30 
2 
0 
8 
74 
32 
2 
268 <β9*> 
32 (62%) 
49 (77X) 
0 ( OX) 
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DIFFERENTTIAL DIAGNOSIS 
It appears that the conjunctival sign can be found only in patients with Hb SS, Hb SC and 
Hb S-beta-thalassemia. 
ETIOLOGY 
Fink et al. (1961) observed the conjunctival sign most frequently in those areas of the 
bulbar conjunctiva that are covered by the upper or lower lid. Using a slit lamp with a 
grading in one ocular to measure the blood flow rate, they observed that Hb SS patients in 
crisis had more marked sludging and slower flow rates than those in a steady state. In one 
case, blood flow returned to normal after the patient was given a blood transfusion. 
Fink (1970), using transmission electron microscopy on excised pieces of conjunctiva of 2 
Hb SS patients, detected no changes in their endothelium, basement membrane or 
pericytes. Tight packing of red cells occurred in a microaneurysm with such marked 
pressure that two adjacent endothelial cells seperated forcefully. An apparent increase in 
the number of plasma cells, as well as the occasional presence of macrophages, suggested 
to Fink that an auto-immune response might be involved in these lesions. 
In patients with HbS-beta-thalassemia, Goldberg and coworkers (1971) were unable 
to identify a correlation between the presence of the conjunctival sign and clinical course, 
age, percentage of hemoglobin S or hematocrit value. Serjeant et al. (1972) and Marsh et 
al. (1982) noted a correlation between the irreversibly sickled cell count (ISC) and the 
number of conjunctival segmentations. 
Using fluorescein angiography, Minatoya et al. (1973) observed non-filling of an 
isolated, comma-shaped vascular segment and an apparent venous stop. 
DISCUSSION 
In patients with Hb SS, the conjunctival sign is highly specific and rather sensitive; it is less 
sensitive, however, in Hb S-beta-thalassemia and Hb SC patients. A correlation appears to 
exist between the number of conjunctival abnormalities and clinical severity - both 
longitudinally per patient and in different Hb genotypes, as evidenced by the rarer 
occurrence of the conjunctival sign in Hb SC and Hb S-beta-thalassemia. 
The conjunctival vasculature has the unique feature of an external high O2 pressure, 
which may explain the lack of correlation of these easily observed rhéologie events with 
vaso-occlusion in other organs. This may also serve to explain why, of all vaso-occlusive 
events, only the conjunctival sign is correlated to ISC count - the pliability of ISCs is not 
improved by high oxygen pressure. 
Most likely, the conjunctival sign represents a stretch of empty vein alternating with 
a dilated and conspicuous segment with erythrostasis. 
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CHAPTER 2 
SECONDARY GLAUCOMA 
INTRODUCTION AND REPORTS 
In non-sickling patients, a traumatic hyphema can lead to glaucomatous atrophy by 
reducing the perfusion in the small vessels supplying the optic nerve head, mostly when 
bleeding was massive, as in an "eight-ball hyphema" (Parrish et al., 1982). 
A similar severe course has been reported (Michelson et al., 1972; Soir et al., 1975; 
Crouch et al., 1976; Radius et al., 1976; Goldberg 1979a,b; Deutsch et al., 1984) in seven 
young adults with sickle-cell trait and only a small hyphema. Obstruction of the central 
retinal artery was observed in four of these patients, while three were noted to have optic 
atrophy. In addition, Friedman et al. (1979) reported transient open-angle glaucoma in 
four Hb AS patients without hyphema, but with blood in Schlemm's canal. 
Another type of secondary glaucoma, neovascular glaucoma, was reported in two 
Hb SS and 3 Hb SC patients (Boniuk et al, 1964; Yanoff et al., 1975; Goldberg et al., 1978; 
Goldberg, 1979b); however, in at least four of these patients, other causes for rubeosis 
iridis, such as diabetes, central retinal vein or artery occlusion, were present. 
CLINICAL RELEVANCE 
Six of 32 reported Hb AS patients with traumatic hyphema suffered severe visual loss 
(hand movements to loss of light perception). 
ETIOLOGY 
In some of the cases presented by Goldberg (1979a,b,c,d), there was a higher proportion of 
sickled cells in the anterior chamber as compared with the number of such cells in their 
peripheral blood. He suggested that, even in cases with partial hyphemas, the sickled cells 
tend to compromise outflow facility; this causes a high intra-ocular pressure that may either 
overcome systolic arterial pressure or slow flow to such an extent that sickling can occur in 
the vessels at the disc or in the central retinal artery. It was observed in a human eye that 
sickled erythrocytes were logjammed in the deep corneoscleral layers of the trabecular 
network, thus impeding the outflow of aqueous humor. Macrophages (with and without 
ingested erythrocytes) and ghost cells were present only in small numbers and did not 
appear to contribute significantly to trabecular blockade; neither was there hemosiderosis 
of the trabeculum. Thus, the mechanism by which outflow became obstructed differed from 
that associated with hemolytic, ghost cell or hemosiderotic glaucoma. 
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DIFFERENTIAL DIAGNOSIS 
Any disorder known to influence optic disc perfusion (e.g., hyperviscosity syndrome, 
diabetes, hypertension or a temporary hypotension, atherosclerosis and vasculitis) could 
hypothetically cause greater than expected disc damage after hyphema and a rise in 
intraocular pressure. A relative small hyphema in combination with a recession of the 
chamber angle may also lead to an unexpectedly high and prolonged rise in intraocular 
pressure. 
TREATMENT 
Goldberg (1979d) and Deutsch et al. (1984) advised against the use of osmotic diuretics, 
such as mannitol, since they are apt to induce more sickling by dehydration. Increased 
sickling also occurs following the use of carbonic anhydrase inhibitors, which induce 
acidosis and raise the level of intracameral ascorbic acid (Goldberg, 1979c). 
In rabbits with experimental sickle cell hyphemas, Jampol et al. (1988) describe the 
use of goggles for the transcomeal delivery of hyperbaric oxygen to unsickle the 
erythrocytes. 
DISCUSSION 
Traumatic hyphemas have not been described in either Hb SS or Hb SC patients. Cases in 
which an unusually severe course accompanies a small hyphema without an obvious 
chamber angle recession may tend to receive more attention when a factor of 
pathophysiological interest may be implied. Nevertheless, if patients with sickle cell trait 
present with a hyphema, emphasis should be placed on the early removal of even small 
amounts of intracameral blood rather than on the prolonged use of Diamox or mannitol 
(Deutsch et al., 1984). 
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CHAPTER 3 
IRIS 
INTRODUCnON 
Patches of iris atrophy, for which there is no apparent cause, are seen in some patients with 
sickle cell disease. 
REPORTS 
In 1973, Calinos and colleagues observed in two Hb SC patients grayish-white atrophic 
patches in the iris stroma without diafany. These eyes, which had not been subjected to 
surgical procedures, also had proliferative sickle retinopathy. Chambers et al. (1974) 
reported a greater degree of atrophy, with full-thickness holes, in both irides of a 26-year-
old woman with HbSC. In both eyes, proliferative retinopathy coexisted. Over an 11-
month observation period, this condition remained unchanged and no glaucoma 
developed. 
After excluding four eyes because of previous detachment surgery or trauma, 
Acheson et al. (1986) reported iris atrophy in 25 eyes of 22 patients: two from a group of 
352 Hb SS patients, along with 17 eyes of males and 3 eyes of females among 455 Hb SC 
patients. Proliferative retinopathy coexisted in 90% percent of the Hb SC-patients. In all 
of these cases, iris atropy involved the pupillary border. The atrophy extended to the 
collarette in nine eyes and to the contraction furrows in nine others. 
ETIOLOGY 
Histology (Acheson et al., 1986) of one case showed stromal necrosis of varying thickness, 
wherein the dilator and sphincter muscles were involved; pigment from necrotic 
melanocytes was dispersed in the stroma. In addition, there was coagulative necrosis of 
blood vessels in the stroma. Apart from sickled red cells, the blood vessels in the ciliary 
body had no abnormalities. Moreover, the pigment epithelium was largely intact. 
DIFFERENTIAL DIAGNOSIS 
Atrophic iris patches have been described in a variety of circumstances: after any anterior 
segment surgery, following trauma, in anterior segment ischemia after retinal detachment 
and strabismus surgery (Ryan et al., 1971), in essential iris atrophy and herpes zoster 
iridocyclitis (Marsh et al., 1974), and subsequent to quinine use (Knox et al., 1966). 
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DISCUSSION 
In sickling patients, iris atrophy is a specific, but rather insensitive, sign of proliferative 
sickle retinopathy and thus has been associated with visual loss in some cases. 
It seems paradoxical that the parapupillary area, which has the greatest opportunity for 
coUateralization, is the region most affected by iris atrophy. Using fluorescein angiography, 
Hayreh (1978) nevertheless found that in the iris (whose circulation is slower than that of 
the choroid or retina) the pupillary area filled last. Near the pupillary border, therefore, 
capillary transit time may occasionally be longer than the delay time of intracellular 
deoxyhemoglobin gelation (Eaton et al., 1976). This situation is apparently more common 
in Hb SC patients. 
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CHAPTER 4 
MISCELLANEOUS POSTERIOR SEGMENT CHANGES 
VITREOUS 
Examination of the vitreous is not reported in the published series; however, its role in 
proliferative sickle retinopathy has been mentioned by Ryan (1975)(see Part IV, chapter 
1). 
TORTUOSITY OF MAJOR RETINAL VESSELS 
REPORTS 
In 1937, Harden reported dilated and tortuous retinal veins as a new diagnostic feature in 
two patients with sickle cell anemia. A fundus photograph clearly validated his finding. 
Lieb et al. (1951) found tortuosity and dilatation of retinal vessels in 22 of 39 Hb SS 
patients and in 4 of 9 Hb SC patients. In 1956, Hannon described 25 of 53 Hb SS cases, but 
only one in 62 Hb AS cases, as having dilated and tortuous veins. Condon (1972a,b,c,d) 
noted tortuosity of major vessels in 10 of 50 Hb S-beta-thalassemia patients, in 22 of 132 
Hb SS patients, and in 8 of 70 Hb SC cases. 
CLINICAL RELEVANCE 
There appeared to be no correlation between the tortuosity or dilatation observed and 
severity of retinopathy, such as in the case of the plus sign in retinopathy of prematurity, 
that indicates a greatly increased risk of developing rapidly progressive fibrovascular 
proliferation (Ben-Sira et al., 1988). 
DISCUSSION 
Although in early reports tortuosity and dilatation of veins were presented as findings 
prevalent in sickle cell patients, such a trend is not clear from a review of later reports. It 
appears that the difficulty of clearly defining tortuosity or dilatation, coupled with its 
perceived lack of clinical relevance, may have served to redirect interest to other aspects of 
retinal involvement in sickling diseases. 
ANGIOID STREAKS 
INTRODUCTION 
Angioid streaks have been noted in conjunction with numerous disorders, including 
pseudoxanthoma elasticum (PXE, an inherited disorder of connective tissue, involving both 
collagen and elastin; Standbury et al., 1978); Paget's disease (a focal disease of unknown 
origin with excessive bone destruction and formation; Avioli et al., 1978); Ehlers-Danlos 
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syndrome (a group of inherited general collagen disorders, Standbury et al., 1978); sickling 
disorders; thalassemia major (Singerman, 1981); spherocytosis (Singerman, 1983,1984) or 
idiopathically. 
REPORTS 
Condon et al. (1976d) reported angioid streaks in 27% of Hb SS patients over 45 years of 
age. Angioid streaks were observed to develop at the age of 25 and 28 years (Hamilton, 
1981) and between 39 and 43 years of age (Condon et al., 1976). 
Eighty-eight percent of reported cases with angioid streaks in patients with a sickling 
hemoglobin occurred in Hb SS patients (Table 3). 
REPORTED 
Author 
Goodnan 
Geeraets 
Lieb 
Paton 
Levine 
Condon 
Nagpal 
Hamilton 
Goldberg 
Clarcson 
OCCURRENCE OF 
Year 
1957 
1960 
1961 
1962 
1963 
1976 
1976 
1981 
1971 
1982 
Total 
MGOID STREAKS IN 
Angoid 
Streaks 
2 
13 
37 
2 
42 
Hb 
SICKLE 
type 
SS 
ss 
ss 
ss 
SC 
ss 
ss 
sc 
s-β 
ss 
s-β 
ss 
se 
ss 
se 
thai 
thai 
Sthal 
»ATIENTS Table 3 
nuiïfcer of patients 
in 
> 
> 
> 
> 
> 
> 
> 
> 
> 
series 
2 
1 
51 
2 
1 
132 
162 
101 
49 
110 
14 
129 SS/ 
SC 
589 
102 
63 
745 
CLINICAL RELEVANCE 
Loss of central vision can occur when choroidal neovascularization, which can occur along 
angioid streaks, involves the macula. Although laser treatment may be of some value, the 
treatment of recurrent neovascularization remains a major difficulty (Gelisken et al., 1988, 
Singerman et al., 1981). Choroidal neovascularization involving the macula had been 
observed in four out of 30 cases with angioid streaks associated with sickle cell disease: two 
by Hamilton et al.(1981; 44- and 47-year-old patients; no measurements of visual acuity 
were mentioned), one by Clarcson et al. (1982; 36-year-old patient) and one by Moriarty et 
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al. (1987; 21-year-old patient). In the latter case, subretinal neovascularization occurred, 
apparently isolated from the angioid streaks. Laser treatment proved successful over a 
follow-up period of nine months. 
ETIOLOGY 
Histologically, angioid streaks have been described as breaks in Bruch's membrane 
(Spencer, 1985). Geeraets (1960) suggested that they may result from degeneration of 
elastic tissue, because of their association with PXE and his own discovery of defects in the 
lamina elastica of several ciliary arteries in two of 16 histologically examined eyes from Hb 
SS patients. 
In 1972, Paton proposed that iron from the severe hemolysis present in patients with 
Hb SS (as, to a lesser degree, in spherocytosis and thalassemia; Singerman, 1983,1984) 
may enter Bruch's membrane and induce calcification. In both Paget's disease and 
acromegaly, the level of alkaline phosphatase is elevated and skeletal changes occur, thus 
suggesting a linkage between abnormal calcification and the development of angioid 
streaks (Paton, 1972). 
Using transmission electron microscopy, Jampol and coworkers (1987) examined 
the eye of a Hb SS case with angioid streaks and noted that Bruch's membrane was 
calcified heavily. They were unable to demonstrate iron deposition. It was suggested that 
calcium imparts an eggshell brittleness on Bruch's membrane, predisposing it to 
mechanical fracture. 
DIFFERENTIAL DIAGNOSIS 
The ophthalmoscopic picture of angioid streaks is typical and they are best vizualised 
during fluorescein angiography. Reporting on 58 such cases, Paton (1972) noted that more 
than half had skin biopsy-proven PXE, while Paget's disease ranked second among the 
verified causes. Other diagnoses included sickling diseases (4 cases), senile elastosis, 
acromegaly and systemic lupus erythematodes. 
DISCUSSION 
A relationship apparently exists between angioid streaks and sickling disease, although 
their occurrence in Hb AS (Gerde, 1974) is probably coincidental. 
In the larger series (Nagpal, Condon, Hamilton; see table 3), angioid streaks have 
been associated primarily with Hb SS and older age. It has been shown by Hamilton and 
colleagues (1981), however, that factors, such as a high percentage of irreversibly sickled 
cells or a low percentage of HbF, while possibly influencing the frequency of vaso-occlusive 
events, did not correlate with the occurrence of angioid streaks. This finding would appear 
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to negate Bonnet's earlier (1933) suggestion that there is an accumulative effect of vaso-
occlusion in the choriocapillaris. There is no histological evidence of this either. 
In Hamilton's, Nagpal's and Paton's patients, skin biopsies served to rule out the co­
occurrence of PXE, thus implying that a different mechanism may be involved in these 
cases. What remains unclear, however, is why an excess of calcium gets deposited in 
Brach's membrane in sickle cell disease, which has no disturbance in calcium metabolism. 
PERIPHERAL COLOR CHANGES 
REPORTS 
Condon et al. (1972a,b,c) described whitish peripheral retinal lesions in 84% of sickle cell 
patients. Nagpal et al. (1975,1976) reported both white and dark peripheral patches, half of 
which occurred, however, in patients without sickle cell disease (Table 4). 
OCCURRENCE OF 
pat 
FAG 
Hb 
η 
пес 
Author 
Condon 
11 
Nagpal 
Nagpal 
Talbot 
X 
S 
X 
3 
s 
1972 
1975 
1976 
1982 
PERIPHERAL 
пшЬег 
of 
COLOR CHANGES 
examined patients 
fluoresceine angiography 
Hb type 
nmfeer of patients with changes 
no consistent changes on FAG 
Pat Hb 
76 SS 
70 SC 
50 Sth 
30 AA 
SS 
AS 
AA 
AS,Sth 
SS, CC 
59 SS 
37 SC 
η 
74 
58 
32 
0 
4 
2 
1 
7 
27 
10 
Reported changes 
whitened retina with 
condensation of basal 
vitreous 
transient brown midperi-
ptieral patches unrelated to 
vitreous adhesions, salmon 
patches or Iridescent spots 
migratory lesions of white 
without pressure,with 
vitreoretmal adhesion 
poorly defined yellow to 
red color changes 
Table 4 
FAG 
ncc 
normal 
normal 
ncc 
COMMENT 
The whitish lesions reported by Condon et al. and Nagpal et al. probably represent "white-
without-pressure", an ophthalmoscopic sign related to vitreoretinal adhesions, without an 
adequately shown increased risk of retinal break formation (Watzke, 1961; Green, 1989). 
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CHAPTERS 
NONPROLIFERATIVE VASCULAR CHANGES 
IN THE POSTERIOR SEGMENT 
CHOROID 
REPORTS 
Four sickle cell patients (2 SC, 1 SS and 1 Sthal) with possible ciliary artery occlusions have 
been reported (Condon et al., 1973; Dizon et al., 1979). Dizon and coworkers were able to 
observe the course of these lesions: midperipheral wedge-shaped whitish areas deep to the 
retina in the acute stage,, which became mottled areas within weeks. As a complication of 
feeder-vessel photocoagulation similar lesions were noted more frequently in sickle cell 
patients (Goldbaum et al., 1976). 
ETIOLOGY 
Two or three posterior ciliary arteries originate from the ophthalmic artery. Near the 
bulbus each ciliary artery splits into many smaller branches (numerous short posterior 
arteries and one long posterior ciliary artery), which penetrate the sclera near the disk and 
more laterally, after which they divide into choroidal arteries. Anatomically many 
anastosmoses are found between the choroidal arteries (Saracco et al., 1984; Yoneya et al., 
1987). 
However, Hayreh (1975), using fluorescein angiography after posterior ciliary 
ligation in primates, maintained that in vivo no functional anastosmoses occur. The 
recurrent triangular lesions in Dizon's patient showed a striking resemblance to the ones 
produced by ligation of the lateral or all ciliaiy arteries in monkeys (Hayreh et al., 1972). 
DIFFERENTIAL DIAGNOSIS 
Sectorial or triangular choroidal infacts have been reported in a number of diseases 
predisposing to vaso-occlusion: i.e. carotid thrombosis, Horton's cluster headache, 
temporal arteritis (Amalric 1971; Foulds et al., 1971; Gaudric et al., 1984) and 
phycomycosis (Bullock et al., 1974). 
COMMENT 
Apart from choroidal occlusions, the Hb SS patient studied by Dizon and colleagues 
showed amaurosis fugax, retinal arteriolar occlusions and occlusion of one internal carotid 
artery. In this patient with an exceptional vaso-occlusive tendency, it is likely that emboli of 
erythrocyte plugs or thrombi from the carotid or opthalmic artery occluded either a ciliary 
artery or simultaneously several short posterior ciliary or choroidal arteries. 
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MAJOR ΚΕΉΝΑί VESSEL OCCLUSIONS 
INTRODUCTION 
Vessel involvement at the posterior pole in sickle cell disease presents a spectrum ranging 
from central retinal artery occlusion to perimacular capillary drop-out, with the formation 
of perifoveal avascular zones. The smaller vessel occlusions are frequently asymptomatic 
and without reduced visual acuity, whereas arterial occlusions usually present with acute 
symptoms of visual loss. 
Peripheral retinal vessel obstructions with capillary loss in large, often confluent 
areas extending from the ora serrata posteriorly are mostly described in relation to 
proliferative retinopathy. In many patients, however, these obstructions do not lead to 
proliferative changes. 
As sequelae to arteriolar obstruction retinal hemorrhages, salmon patches, 
iridescent spots and black sunbursts are grouped together. 
REPORTS 
In four sickle cell patients central retinal artery occlusions have been reported; in one it 
occurred after retrobulbar injection. Symptomatic branch and macular artery occlusions 
occurred in eight sickle cell patients; visual loss was often relatively mild (Table 5). 
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SYMPTOMATIC 
Site осе I 
ca 
ba 
cv 
VA 
Author Year 
Kabakov 
Goodnan 
Lieb 
Conrad 
Condon 
Acacio 
Knapp 
Ryan 
Chopdar 
Appen 
Ueissman 
Klein 
Asdourian 
Condon 
Tota 
VESSEL OCCLUSIONS IN SICKLE CELL 
= site of 
» central 
occlusion 
retinal artery 
• branch retinal artery ma 
= central retinal vein rel 
= visual acuity 
Hb|Age 
1 
1 1 
'55|AS 
'57|SS 
'61|SS 
I» 
'67|AS 
'72|SS 
'73|SS 
'72|SS 
'74|SC 
'75|SC 
'75|Stf 
|AS 
'79|SS 
'82|SC 
|SC 
'e2|Stl· 
'85|SS 
Site|Ret 
36 
18 
3 
г 
32 
13 
15 
10 
24 
22 
44 
64 
25 
43 
33 
14 
20 
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4 
4 
2 
осе I 
ca 
ba 
cv 
cv 
ca 
ba 
ca 
ma 
ma 
ba 
ca 
ca 
ba 
ca 
ca 
ma 
ma 
ca 
ba 
ma 
cv 
PATIENTS Table 5 
= macular arteriole 
.edema = retinal edema 
|Final|Pale| 
edema 
+ 
+ 
? 
+ 
+ 
-
-
+ 
·> 
? 
+ 
-
+ 
+ 
+ 
(3 AS 
VA 
NLP 
CF 
7 
? 
NLP 
1 
0,1 
0.1 
1,0 
0,2 
? 
? 
0,8 
1,0 
NLP 
0,5 
1,0 
2 SC 
Remarks 
disk] 
1 
+ 
+ 
1 
I 
| SLE.active tbc 
| subarachnoid 
| hemorrhage 
| both eyes 
| both eyes 
| after retrobulbar 
| injection 
| recurrent 
SS, 1 Sth) 
COMMENT 
Although major retinal arterial occlusions cause severe visual symptoms only one central 
retinal occlusion (following retrobulbar anesthesia, Klein et al., 1982) and two minor 
branch occlusions were noted over a period of 15 years in approximately 800 Hb SS and 
300 Hb SC patients in Jamaica (Condon et al., 1972a,b; Condon et al, 1985). Since an 
association with sickling disorders tends to hasten reporting, there may be underreporting 
on "idiopathic" young patients with these occlusions. Major retinal artery occlusions in 
sickling disorders remain very uncommon and, judging by the frequency of reported cases, 
might even be a chance correlation. 
Interestingly, there is no mention in the literature of an increased occurrence of 
central or branch vein occlusion in sickle cell patients. Only Lieb and coworkers (1961) 
mentionned two cases with possible central vein occlusion. In both cases, which had a 
subarachnoid hemorrhage, the drawings could have also represented severe disk edema. 
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SMALL VESSEL OCCLUSIONS IN THE POSTERIOR POLE 
REPORTS 
Stevens et al. (1973) and Asdourian et al. (1976) reported abnormalities in either or both 
the macula and temporal raphe in 32% of Hb SS patients, 36% of HB SC patients and in 
20% of S-beta-thal patients in 100 consecutive cases. The macular abnormalities consisted 
of cotton-wool spots, microaneurysm-like dots, dark and enlarged segments of arterioles, 
hairpin-shaped venular loops and on, fluorescein angiography, of pathological avascular 
zones (PAZ) and widening and irregularities of the foveal avascular zone (FAZ). In 
children, Talbot et al. (1982) found no pathologic avascular zones in the macular region (59 
Hb SS and 37 Hb SC patients ranging from five to eight years). 
Goldbaum (1978) described the retinal depression sign on ophthalmoscopy, which 
followed the disappearance of cotton-wool spots and was thought to result from local 
thinning after necrosis of an infarcted inner retina. 
Transient dark spots, apparently plugged deoxygenated erythrocytes within small 
surface vessels, were noted on the disk itself in 9 (7 Hb SS), of 80 sickle cell patients 
(Goldbaum et al., 1978) and in 17 of 74 Hb SS patients (Condon et al., 1972a). 
COURSE 
Some patients with cotton-wool spots were observed longitudinally (Asdourian et al., 
1976); at these sites, abrupt stops in the adjacent arteriole were seen on fluorescein 
angiograms, with subsequent opening and reclosing of the initially non-perfused arteriole. 
In some cases, the dependent capillaries also reperfused. Venular loops were found to 
develop adjacent to areas that remained non-perfused. 
Marsh et al. (1982) observed an inverse relationship between the number of 
perimacular capillary abnormalities and the size of the FAZ; they also noted that a small 
FAZ and a high count of these capillary abnormalities were more common in younger than 
in older patients, suggesting that perimacular vessel abnormalities represent the early vaso-
occlusive phase that may progress to enlargement of the foveal avascular zone. 
CLINICAL RELEVANCE 
In only three of the patients studied by Stevens and Asdourian, a visual loss in the range of 
20/25 to 20/30 could be attributed to a macular cause. One eye in Asdourian's series had a 
paracentral scotoma with a deutan defect on the Farnsworth D-15 panel. In only three 
cases could field defects be related to these lesions by static perimetry. However, using the 
Farnsworth-Munsell 100-hue test, Roy et al. (1987) demonstrated mild to moderate yellow-
blue defects in nearly all 61 eyes of sickle cell patients; there was no correlation with 
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pathologic avascular zones or retinal depression signs. Mild defects were found in one third 
of the control subjects. 
COMMENT 
These results have not shown that these chronic, remodeling small vessel changes cause 
significant functional loss. Furthermore, there is no mention in the reports concerning 
elderly sickle cell patients of major visual loss in association with ischemic maculopathy, 
which would be expected if these changes were progressive. 
Interestingly, no specific mention is made in these papers of the coexistence of 
peripheral retinopathy: apparently, there is no strong correlation between the extent of 
peripheral non-perfusion and non-perfusion along the raphe, in spite of the similarities in 
vasculature in these two regions (Stevens et al., 1976). 
PERIPHERAL VESSEL OCCLUSIONS 
INTRODUCnON 
Teleangiectasias, microaneurysms and dilatations are signs of the mild and moderate stages 
of peripheral micro-angiopathy according to Condon et al.'s (1972a) classification. Vessel 
sheathing and silver-wire appearance can be manifestations of obstruction: this has been 
classified by Condon (1972a) as the severe stage, and by Goldberg (1972) as stage I. 
REPORTS 
In Condon's series there is not a apparent difference between Hb SS (24%) and Hb SC 
(31%) patients in the prevalence of peripheral obstructions; Talbot noted a greater number 
of obstructions in Hb SS children (Table 6). 
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OCCURRENCE 
η 
teleeng. 
mîcroen. 
a-v «nast. 
Author 
Hennon 
Goodnan 
Lieb 
Munro 
Uelch 
Condon 
H 
Talbot 
OF PERIPHERAL VESSEL OBSTRUCTIONS Table 6 
« пмЬег of patiente 
« teleangfectasiae 
- microaneurysms 
• arteriovenous anestosmos 
year 
'56 
'57 
'61 
'60 
'66 
'72a 
η 
3 
1 
51 
9 
9 
35 
23 
74 
'72b 70 
'72c 
•82 
50 
59 
37 
кь 
sc 
ss 
ss 
sc 
sc 
SS 
sc 
SS 
sc 
Sth 
SS 
sc 
tele micro 
ang. an. 
27 
22 
10 
si 
is 
l ver 
wire 
1 
1 
9 
obstr sheath a-v 
uction ing anast. 
38 
5 
1 
17 
16 
18 5 
22 19 
7 
14 30 0-3 
6 11 « 
COURSE 
Calinos et al. (1975) showed, prospectively, a continuous remodeling of the peripheral 
retinal vasculature due to successive closures and reopenings of equatorial retinal vessels. 
Nevertheless, a centripetal (posterior) recession of the peripheral retinal vasculature 
usually resulted. 
Raichand et al. (1977), who followed 40 sickling patients with peripheral 
obstructions and arteriovenous anastosmoses, observed the formation of four seafans from 
arteriovenous anastosmoses of these cases. These anastosmoses had been observed to exist 
for seven months to three years prior to seafan formation. 
CLINICAL RELEVANCE 
No loss of visual acuity had resulted from these peripheral occlusions ; moreover, no visual 
field loss had been detected (Calinos et al., 1975). However, peripheral vessel closure and 
capillary bed drop-out can be the setting for proliferative sickle retinopathy, to be discussed 
in chapter 6. 
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ΚΕΉΝΑΙ. HEMORRHAGES, SALMON PATCHES, IRIDESCENT SPOTS AND 
BLACK SUNBURSTS 
INTRODUCTION 
Hannon (1956) used the term "salmon-pink exudative plaque" for what has been shown to 
be a round or oval shaped intra- or pre-retinal hemorrhage, as distinguisheded from a more 
diffuse intra-vitreal hemorrhage or clearly subhyaloid hemorrhage. 
Glinstering deposits (Levine et al., 1965), refractile and lipid deposits (Welch et al., 
1967), cholesterol deposits (Lieb et al., 1961) and iridiscent glinstering deposits (Condon 
et al., 1972a) are terms that have been used to describe the small crystal-like deposits seen 
superficially in the retina in sickling patients. They are often observed in association with 
mottled or pigmented round areas. 
The deep retinal plaques of stellate or spiculate pigment dispersion, seen in the 
midperiphery in sickling patients, were termed "black sunbursts" by Welch et al. (1967). 
REPORTS 
Compiling the pertinent reports it appears that iridescent spots, salmonpatches, retinal 
hemmorhages, brown patches and black sunbursts (either one of these signs or a 
combination of them) are noted in two-third of either SS, SC or S-beta-thalassemia 
patients (Table 7). 
REPORTED 
η = 
Hb -
ret hem · 
salmon = 
Author 
Cook 
Hennon 
Goodnan 
Lieb 
Levine 
Welch 
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'72 70 
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dep » iridescent spots 
mottled br ar = mottled brown area's 
black sunb 
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mon 
1 
Ігі 
dep 
12 
3 
4 
10 
8 
10 
23 
9 
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Mottled 
br.areas 
10 
11 
13 
22 
sunburst 
Black 
suib. 
1 
23 
5 
15 
4 
25 
33 
10 
Table 7 
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CLINICAL RELEVANCE 
Even when these retinal hemorrhages occasionnaly break through the internal limiting 
membrane into the vitreous, they do not interfere with visual acuity, being both small and 
peripheral. 
COURSE 
Asdourian et al. (1975) observed a retinal hemmorrhage gradually turn into a black 
sunburst lesion. Similarly was the transformation of salmon patches into round, pigmented 
patches with iridescent spots. 
Using light microscopy, Romayananda et al. (1973) found hemosiderin- laden 
macrophages either preretinally, in "schizis cavities" formed by the internal limiting 
membrane and inner retina, or between sensory retina and retinal pigment epithelium. In 
the latter case, there was focal pigment epithelial hypertrophy, hyperplasia and migration. 
Apparently, a burst-out hemorrhage from a retinal arteriole or capillary can give rise to 
different ophthalmoscopic signs after its absorption, depending upon its exact location and 
consequent plane of dissection: from preretinal iridescent spots, via a round or oval schizis 
cavity with or without iridescent spot or brownish pigment to the deeper retinal and 
pigment epithelial scar known as the black sunburst. 
COMMENT 
Although these patches do not by themselves cause visual loss, they are related to 
occlusions of small vessels, burst-out hemorrhages and capillary loss. Talbot et al. (1982) 
did show a correlation between the patches and capillary closure in a series of 96 young 
children. 
Interestingly, despite the fact that these different signs of vaso-occlusion are often 
accompanied by the loss of retinal perfusion and thus are a factor in the occurrence of 
proliferative sickle retinopathy (PSR) they are not more common in Hb SC patients, where 
PSR is frequent. 
ETIOLOGY OF VASO-OCCLUSION IN THE CHOROID AND RETINA 
Local plug formation occurs in small vessel occlusions, although there is uncertainty with 
respect to its exact site. 
Irreversably sickled cells (ISC) and dense discocytes (Fabry et al., 1985) are those 
red cell fractions most likely to plug the small vessel bottleneck, the precapillary arteriole 
(Klug et al. 1974). In stagnant blood even the other two fractions of sickling blood 
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(reticulocytes and reversibly sickling cells) will sickle. In contrast, the latter two red cell 
classes, which are rheologically quite normal in the oxygenated state, can pass their delay 
time of mtracellular gelation and sickle during capillary and venular transit. On fluorescein 
angiograms, non-perfused capillary beds are sometimes associated with abrupt arteriolar 
stops, which prompted Goldberg (1976) to propose arteriolar occlusion as the initial site. 
However, primary capillary plugging with retrograde jamming may also lead to the 
accumulation of sufficient dye and produce the characteristic arteriolar stump on 
fluorecein angiography. 
The complex remodeling of temporarily occluded and non-perfused arterioles and 
capillaries would suggest plugging rather than thrombosis. However, recanalisation of a 
true thrombus may also occur. Emboli are usually implicated in larger artery occlusions. 
Chopdar's (1975) observation of simultaneous separate occlusions suggests embolism, 
possibly of sickled erythrocyte plugs, as cause of occlusion. Likewise, Dizon's case (1979) 
showed simultaneously retinal and ciliary occlusions. Stockman et al. (1972) mentioned 
thrombus formation in large cranial vessels as a source for emboli, possibly due to 
involvement of their vasa vasorum. Further retrograde intraluminal plugging after 
occlusion by an embolus may worsen the effect of occlusion, as suggested by the disk 
infarction noted in some cases with central artery occlusion (Table 4). 
The hemorrhages observed by Chopdar (1975) indicate that, at the site of occlusion, 
a blow-out of the (possibly ischemic; Jampol et al., 1981) vessel wall had occurred. A 
stranded embolus, with a consequently sudden build-up of intraluminal pressure is more 
likely to be the initiating event than would be a presumably slower local plug formation. 
The different appearances of vaso-occlusion i.e. hemorrhages, cotton-wool spots, 
retinal depression sign and non-perfused areas may be determined by such interrelated 
factors as the mechanism of vaso-occlusion, vessel size, pressure head, flow velocity, 
possibilities of collateralization and thickness of the inner retina -- all factors determined 
by the topical anatomy of the retina. Arterial diameters decrease progressively from the 
disk outward. Blood pressure on the arterial side drops off suddenly at the precapillary 
arteriole, while flow velocity decreases in a more gradual fashion. The three-layered 
capillary bed, that supplies the centrally thicker inner axonal and nuclear layers, thins out 
into one layer in the thin anterior periphery and horizontal raphe. Around the disk and 
along the major vessels a fourth superficial capillary bed exists (Henkind 1969). Relatively 
long, looping, anastosmotic capillaries were angiographically documented at the far 
periphery of the vascularized retina (Asdourian et al., 1979). 
Cotton-wool spots may occur after occlusion where either pressure build-up, 
sufficient for vessel rupture, was prevented by shunting due to the presence of the fourth 
capillary layer or where tissue pressure prevented a burst-out. Alternatively, only in the 
thick nerve fiber layer in this area inner retinal infarction produces a visible sign. 
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Salmon patches are generally found at more peripheral sites and are likely the result 
of a rather sudden arteriolar obstruction, when a in a previous occlusive episode 
ischemically or mechanically weakened vessel wall raptures. Less tissue pressure and less 
shunting may be other factors involved in allowing the salmon patch to occur. 
At the horizontal raphe and the peripheral retina, the pressure gradient may be too 
low and the tissue too thin to produce bleeding or visible infarction, possibly because 
occlusion is a more gradual capillary stasis. 
DIFFEREOTIAL DIAGNOSIS 
Central or branch retinal artery occlusions generally occur in elderly patients with other 
symptoms of severe atherosclerotic carotid and cardiac valvular disease, associated with 
high mortality (Hayreh et al., 1982; Karjalainen, 1973). The workup should focus on these 
diseases and their risk factors, such as diabetes and hypertension, while excluding rarer 
systemic causes, such as systemic lupus erythemathodes and lues (Appen et al., 1975). 
Emphasis should be placed on the prompt diagnosis of temporal arteritis (Appen et al., 
1975), since immediate treatment may prevent the involvement of the second eye. In ten of 
Appen's patients, who were under forty years of age, polycythemia vera, atrial myxoma and 
cardiac valvular disease in Marfan's syndrome were found; in four no predisposing factors 
were found. 
Small vessel occlusions with formation of retinal infarcts or hemorrhages, can occur 
in a wide variety of vascular and intravascular diseases. Diabetes mellitus, hypertension 
and vasculitis of auto-immune (SLE; Jabs et al., 1986) or infective origin (cytomegalovirus, 
lues; Savir et al., 1976) are considered "vascular" causes, whereas a hyperviscous state 
(macroglobulinemia) and emboli are examples of intravascular causes. 
Peripheral vessel closure can be observed in Coats' disease (van Nouhuys, 1982), in 
Wagner's hereditary vitreoretinal degeneration (Jansen, 1966; van Nouhuys et al., 1981), in 
myopic eyes of healthy subjects (Miyakubo et al., 1980), and possibly in normal eyes 
(histology; Spitznas et al., 1977). Moreover, peripheral retinal vessel closure occurs in 
nearly all conditions associated with peripheral retinal neovascularizations. 
Although salmonpatches have been reported as such only in sickling patients, any 
small oval or round subhyaloid or subinternal membrane hemorrhage that hemolyses, may 
be similar in appearance. 
Black sunbursts resemble any peripheral chorioretinal or deep retinal scar of 
approximately two to four disk diameters in size. Therefore toxoplasma scars would appear 
more similar than toxocara scars on the one hand or histoplasma on the other hand. 
Erlschnig's spots (choroidal infarcts in patients with malignant hypertension) tend to be 
smaller and without spiculate hyperpigmentation (Morse, 1968). Pavingstone degeneration 
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is generally more peripheral, more rectangular, larger and more atrophic in appearance. 
Interestingly, Spitznas et al. (1975) observed black sunbursts in patients with Eales' disease. 
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CHAPTER 6 
PROLIFERATIVE SICKLE RETINOPATHY 
INTRODUCTION 
Retinal and, in rare instances, disk neovascularization in sickling patients have been 
reported as retinitis proliferans (Henry et al., 1954, Condon et al., 1972) and as seafans 
(Welch et al., 1966). Some of these cases progressed to vitreous hemorrhage and retinal 
detachment, thus proving to be a sight threatening variant of sickle retinopathy. 
CLASSIFICATIONS OF SICKLE CELL RETINOPATHY 
Lieb et al. (1961) proposed that sickle cell retinopathy be classified as grade II, when 
accompanied by ischemic areas with retinal edema, sheathing of peripheral vessels, 
neovascularization, microaneurysms and peripheral telangiectasis. Grade ΙΠ comprised of 
retinal hemorrhages, iridescent spots and obstruction of small veins. Retinitis proliferans, 
vitreous hemorrhage and central artery or vein occlusion constituted grade IV. Tortuosity 
and dilatation of the major retinal vessels were designated grade I. Lieb et al. felt that the 
higher the grade of retinopathy, the more severe the clinical course of the patient had 
been. 
Goldberg (1971) proposed a classification of proliferative sickle retinopathy, that 
was both clinically useful and pathogenetically logical. According to Goldberg, peripheral 
arteriolar obstruction constituted stage I. Peripheral arterio-venous anastosmoses, judged 
to be sequential to the obstructions, were designated stage II. Peripheral retinal 
neovascularization originating from the anastosmoses was called stage III. Vitreous 
hemorrhages from such neovascularizations were called stage IV. Partly tractional, partly 
rhegmatogenous (due to tears adjacent to seafans with vitreous traction) detachments were 
called stage V. The extent of circumferential involvement was quantitated in substages. 
Condon et al. (1972a) proposed a subdivision of Goldberg's stage I, in which arteriolar 
obstruction constitutes the most advanced abnormality. 
REPORTS 
Reports pertaining to the occurrence of proliferative sickle retinopathy are listed in Table 
8. Only Condon's series (1972a,b,c) have not been selected specifically on the basis of 
ocular symptoms. Proliferative retinopathy was present in 3% of the Hb SS patients, in 
33% of the Hb SC patients and in 18 % of Hb-S-beta thalassemia patients. In Hb SC 
patients 31% of these eyes progressed to vitreous hemorrhage and 15% to retinal 
detachment. With the exception of one case with an exudative detachment (Durant et al., 
1982), all other reported cases of retinal detachment in proliferative sickle retinopathy 
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were either tractional or a combination of tractional and rhegmatogenous. 
REPORTED PROLIFERATIVE 
η » пшЬег of 
Hb »Hb type 
PSR · proliferai 
Author 
Edington 
Henry 
Harmon 
Goodnan 
Lieb 
Munro 
Rubinstein 
Welch 
Goldberg 
Condon * 
Condon * 
Hayes * 
Lewie 
Talbot 
Durant 
К i rane I 
Total 
RETINOPATHY IN NON 
patients 
ive sickle 
retinopathy 
Year 
'52 
'54 
'54 
'56 
'61 
'60 
'67 
'66 
'71 
'72a 
•72b 
'72c 
'72d 
'80 
II 
'B1a 
η 
1 
9 
1 
20 
5 
51 
9 
9 
9 
35 
22 
24 
76 
70 
50 
60 
115 
157 
39 
261 
'Bib 243 
'86 
'83 
'88 
'82 
'87 
-
35 
24 
59 
37 
1 
135 
Hb 
SS 
SS 
SC 
sc 
sc 
ss 
sc 
sc 
sc 
SS 
sc 
sc 
SS 
sc 
Sth 
SS 
SS 
sc 
sth 
SS 
sc 
SS 
sc 
SS 
sc 
sc 
SS 
or SC 
525 
470 
50 
SS 
sc 
Sth 
vitr hen 
ret det 
* 
Nmber of 
III 
2 
4 
4 
9 
1 
12 
4 
3 
13 
39 
3 
38 
9 
12 
29 
75 
6 
29 
90 
7 
17 
-
1 
2 
5 
51 
184 
9 
Stage 
IV 
1 
1 
4 
9 
4 
1 
5 
14 
1 
11 
2 
5 
11 
1 
2 
5 
11 
63 
3 
TREATMENT SERIES Table 8 
» vitreous hemorrhage 
• 
• 
eyes 
V 
1 
1 
2 
2 
4 
4 
1 
1 
1 
2 
5 
2 
15 
" 
retinal detachment 
(partly) the same 
patients 
Nunber of patients 
with stage III 
(where clearly indicated) 
2 
23 
9 
8 
23 
63 
5 
33 
NON-PERIPHERAL PROLIFERATIVE LESIONS 
Neovascularization on the disk has been reported in 4 Hb SC patients (Raichand et al., 
1977; Ober et al., 1978, Condon et al., 1980a; Kimmel et al., 1986) and one Hb SS case 
(Condon et al., 1972a). More peripheral neovascularizations were also evident in these 
patients. In three cases efforts were made to exclude other causes for retinal or disk 
neovascularization. 
NATURAL HISTORY OF PROLIFERATIVE SICKLE RETINOPATHY 
REPORTS 
In patients with proliferative sickle retinopathy (PSR), there is a tendency for a slow 
increase in the extent of neovascularization, as well as in the incidence of vitreous 
hemorrhage and retinal detachment (Table 9). 
The youngest patient with reported PSR was a 8-year-old boy with Hb SC (Talbot et 
al., 1988). The prevalence of PSR increased from the age of 15 years (Hayes et al., 1981a,b) 
to the age of 35 years, after which time a plateau was reached. 
Analysing 114 eyes with PSR Condon et al. (1980) found auto-infarction and 
increased neovascularization to occur simultaneously in the same eye in 32 eyes (28%). 
PSR was observed to develop (46 eyes) most commonly in patients under the age of 25 
years. The most florid growth of neovascularization accorred also in this age group. The 
average age of patients with auto-infarction alone (11%) was higher than that of patients 
with an increase in number of seafans (30%). 
In Jampol and colleagues series (1983) only four of the 22 vitreous hemorrhages 
interfered with visual acuity. Within this series risk factors for vitreous hemorrhage were 
the Hb SC genotype, the initial presence of vitreous blood, and more than 60 degrees of 
perfused seafans (Condon et al, 1983). 
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ETIOLOGY OF RETINAL NEOVASCULARIZATION 
Research relating to the causes of proliferative sickle retinopathy can be divided into two 
primary areas: (1) the pathogenesis of retinal neovascularization itself, mainly in other 
retinal vascular diseases, such as diabetes, vein occlusions and retinopathy of prematurity, 
and (2) the identification of clinical characteristics, that predispose to proliferative sickle 
retinopathy and that might suggest pathogenetic clues. 
Theories regarding retinal neovascularization should preferably explain the 
following: 
- peripheral and disk neovascularization in relation to non-perfused retinal area's, 
- rubeosis iridis and its increased incidence after vitrectomy with lensectomy (Rice et al., 
1980); and the occurrence of rubeosis iridis without retinal or disk neovascularization after 
central retinal vein occlusion (Laatikainen et al., 1977), 
- the therapeutic influence of panretinal photocoagulation and vitrectomy on retinal 
(Diabetic, RSRG 1978) and iris (Tasman et al., 1980) neovascularization, 
- the occurrence of retinal neovascularization in non ischemic retinal disease such as uveitis 
(Shorb et al., 1976). 
ANGIOGENESIS FACTOR STIMULATING THEORY 
Michaelson (1948), studying embryonic vascularization in the kitten retina, suggested the 
existence of a biochemical factor responsible for the growth and development of the retinal 
vasculature. In an experimental model of retrolental fibroplasia Ashton et al. (1954) 
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produced retinal vaso-obliteration by a high oxygen environment, and suggested that 
Michaelson's vasoformative factor was released from areas of hypoxic retina previously 
nourished by the obliterated vessels. This concept was further advocated by Wise (1957), 
who proposed that this factor ("factor X") was operative in all cases of retinal 
neovascularization. Recent research modifies this view and stresses that, in the premature 
retina, which is not yet well protected by anti-oxidants, oxygen from the choriocapillaris 
(rather than the lack of it) damages the spindle cells (vessel precursor cells), and that these 
damaged cells may form factors that induce neovascularization (Hittner et al., 1988). 
Laboratory research geared towards isolating and identifying this factor was triggered by 
the isolation of a tumor angiogenesis factor (Folkman 1974; Finkelstein et al., 1977). 
Subsequently, Glaser et al. (1980) reported angiogenic activity of human, bovine and rabbit 
retinal extracts. However, current research (Kuwishama et al., 1988, MacCumber et al., 
1988, Jerdan et al., 1988) shows that, in RPE, the extracellular matrix and retinal 
endothelial cells, there are a number of both inhibiting and stimulating factors for the 
different steps in new vessel formation. What actually occurs, therefore, is much more 
complicated than one factor X. Glaser (1988) proposed the term "a balance of extracellular 
modulating factors". Petty et al. (1988) showed that sera of diabetic patients with both 
nonproliferative and proliferative retinopathy stimulated large and small vessel endothelial 
cell growth in vitro, whereas this effect was not found with sera from controls. Although 
this factor could have been produced in the eye, it was thought more likely to bre produced 
elsewhere in the body. In patients with proliferative retinopathy, this activity was 
significantly more pronounced. Although this factor could have been produced in the eye, it 
was more likely produced elsewhere in the body. 
In diabetics Shimizu et al. (1981) showed a positive correlation between the extent 
of nonperfusion and the occurrence of retinal, disk and iris neovascularization, 
respectively, implying that the quantity of the factor produced and its diffusion might be 
responsible. Foulds (1980) speculated that laser-coagulated RPE would facilitate diffusion 
of the angiogenesis-stimulating factor away from the retina, as would vitrectomy (Michels 
1978). A third possibility may be that laser coagulation liberates a vaso-inhibitive factor; 
there is some support for this concept in the finding of endothelial cell inhibition by 
vitreous from lasered eyes (Singh et al., 1988). 
VESSEL STRETCH THEORY 
Wohlbarst et al. (1981) and Stefansson et al. (1983) proposed an alternative theory to 
explain retinal neovascularization, in which vessel wall stretch is the main initiating event. 
Since retinal venous pressure in the eye is not much different from intraocular pressure, 
any pressure rise will multiply transmural venous pressure and lead to significant stretch of 
the single endothelial and pericytal layer of venules, resulting in leakage, endothelial 
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proliferation and the formation of new vessels. Particularly in an arteriovenous shunt 
pressure rise will cause significant wall stretch. Therefore, there is an apparent correlation 
with Goldberg's (1971) observation that neovascularization starts at the venous side of 
arteriovenous shunts. 
Hyperglycemia may increase retinal oxygen uptake in dogs (Goldstick, 1981) and 
impair vasoconstriction after oxygen breathing in volunteers; this autoregulatory 
vasoconstriction is impaired in diabetics (Siecker et al., 1953). Zuckerman et al. (1980) 
found that the photoreceptor-RPE complex accounts for two-thirds of the retinal oxygen 
consumption in bullfrog retina. By destroying this receptor-RPE complex through the use 
of photocoagulation, oxygen diffusing from the choriocapillaris can meet the oxygen 
demand of the inner retina. Experimentally, oxygen tension over laser-treated areas 
increased (Stefansson et al., 1987). This correlates with the constriction (presumably by 
autoregulation) of retinal vessels in priliferative diabetic retinopathy after panretinal 
photocoagulation (Wilson et al., 1988). In that way vessel wall stretch leading to 
microaneurysms and neovascularization may be reversed. 
Rubeosis iridis and disk neovascularization are explained as vasodilatations as a 
autoregulatory reaction on ischemia, with resulting wall stretch and neovascularization. 
Vitrectomy may improve oxygenation of the retina by allowing aqueous, with its higher 
(than vitreous) oxygen concentration, to reach the retina, inducing vasoconstriction. 
However, by this increased oxygen consumption after vitrectomy and lensectomy aqueous' 
oxygen could drop to a point that causes iris vasodilatation and subsequently rubeosis. disk 
neovascularization in patients with uveitis, without capillary closure (Shorb et al., 1976), 
suggests that inflammation by itself may cause neovascularization. Stefansson et al. (1983) 
proposed that, in inflammation, various vasodilatatory agents are produced which, again 
due to wall stretch initiate neovascularization. 
ROLE OF THE VITREOUS 
Davis (1965) showed that vitreous detachment was necessary for (preretinal) extension of 
neovascularization in diabetics and emphasized the scaffold function of the posterior 
vitreous face. This concept is supported in view of the rare occurrence of 
neovascularization after vitrectomy and complete posterior detachment (Rice et al. 1983). 
Ryan (1975) felt that the vitreous played a similar role in PSR as in diabetes. He proposed 
that leakage of proteins, erythrocytes and macrophages led to changes in the collagen and 
hyaluronic acid of the overlying vitreous . The altered vitreous might then contract or 
collapse and pull adhering neovascular vessels forward. In fact, Paylor et al. (1986), using 
fluorophotometiy, found alteration of the blood retinal barrier and indications of a 
disturbed vitreous gel structure only in PSR patients. 
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Vitreous traction on vessels might induce neovascularization by wall stretch 
(Stefansson et al., 1983); experimentally sutures appeared to act in such a manner 
(Yamashita et al., 1988). One of the mechanisms of regression of neovascularization after 
vitrectomy could be the release of this traction. 
COMMENT 
These different theories on neovascularization are not mutually exclusive. A net 
vasostimilating action, mediated by different modulating factors released by neighboring 
tissue or serum, will underlie the clinically observed new vessel growth. Vessel stretch, 
hypoxia, relative hyperoxic damage or unknown factors may initiate this process. 
CLINICAL CORRELATIONS 
Research that attempted to determine factors correlating with the clinical course, was 
performed primarily in Jamaica by Serjeant and his coworkers. Investigating hematologic 
indices in a group of 261 Hb SS patients of which 29 had developed PSR, Hayes et al. 
(1981a) found a high Hb level (> 9 g/dl) and a low HbF level (< 5%) constituted a risk 
factor for PSR in males only. Among 243 Hb SC patients of which 90 had developed PSR, 
Hayes (1981b) found a high mean cell hemoglobin concentration in males and a low fetal 
hemoglobin concentration in both sexes to be significantly more common in PSR. 
PSR was more frequently (14%) found in Hb SS patients 40 year of age and older.In 
Hb SS patients aged 40 years or over PSR was more common (14%). PSR was observed to 
develop most often between the ages of 20 and 30 years; 68% of Hb SC patients aged 45 
years or over were affected. 
Talbot et al. (1982a) reporting on the 59 Hb SS and 37 Hb SC children ranging from 
five to seven years old (cohort) found retinal closure to be consistently more common in 
Hb SS chidren; however, this difference did not reach statistical significance. In the same 
cohort, Talbot et al. (1983b) found that retinal closure was closely correlated with low 
total hemoglobin concentration and fetal hemoglobin concentration, high reticulocyte and 
ISC in Hb SS disease and with high reticulocyte counts in Hb SC disease. There was no 
apparent relationship between vessel closure and clinical events like dactylitis, pneumonia, 
crisis and infarction, gastroenteritis, weight loss and fever in either genotype. In a follow-up 
report on the same cohort six years later, these observations held true (Talbot et al, 1988). 
In both SS and SC patients BE Serjeant et al. (1984,1986) compared plasma and 
serum viscosity, whole blood viscosity and erythrocyte filterability in age- and sex-matched 
pairs with or without PSR (27 Hb SS pairs, 31 Hb SC pairs). Hb SC patients with PSR 
showed significantly higher mean cell hemoglobin and lower HbF levels; however, the 
viscosity and erythrocyte filtration indices did not differ between the two groups. Hb SS 
patients with PSR showed a higher Hb and lower HbF in males and a higher mean cell 
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hemoglobin concentration in females. In males with PSR, significantly higher whole blood 
viscosity was measured at high shear and at the patient's own hematocrit. 
Electroretinograms from patients with PSR showed reduced a-wave-, b-wave- and 
oscillatory potential-amplitudes, possibly due to photoreceptor dysfunction secondary to 
choroidal ischemia or increased oxygen demands by the inner retina (Peachy et al., 1987). 
Ischemia of the inner retina may also have contributed to the altered b-wave and 
oscillatory potentials. The same group (Gagliano et al., 1989) found a negative correlation 
between the ERG amplitude measurements and capillary nonperfusion. 
In summary, although the most active phase of PSR was between 20 and 30 years of 
age, there appears to be a cumulative effect with age. Factors that increase sickling per cell 
(such as a high mean cell hemoglobin concentration and low HbF) and red cell numbers 
(such as HbSC) lead more frequently to PSR. The most prominent correlation is that 
between PSR and Hb SC. 
No reports have indicated that peripheral closure is clearly more extensive in Hb SC 
than Hb SS patients. Indeed, in the children's cohort the reverse was shown. To try and 
explain the different incidence of PSR in HbSS and HbSC patients, BE Serjeant et al. 
(1984,1986) and GR Serjeant (1985) hypothesized that, due to the high obstructive 
tendency in Hb SS there would be a high prevalence of retinal infarction, in addition to 
early auto-infarction of developing neovascular tissue. In Hb SC retinal infarction would 
develop; however, due to the moderate vaso-occlusive tendency in Hb SC auto-infarction 
of neovascularizations would be rare. An alternative hypothesis by Serjeant (1985) 
postulates that the greater vaso-occlusion in HbSS disease results in dead retina, which 
fails to release a vaso-proliferative substance, whereas the lesser vaso-occlusion in Hb SC 
disease might allow for the persistence of ischemic retina (refer also to chapter 14). 
DIFFERENTIAL DIAGNOSIS 
Peripheral neovascularization has been reported in a variety of disorders, which I have 
divided into those in which avascular retina is predominant and those where inflammation 
is more conspicuous (Table 10). An ophthalmological examination may be all that is 
needed to alert one to most of these diagnoses: toxoplasma scars, talc emboli, retinal 
detachment, birdshot lesions, old central or branch vein occlusion patterns or peripheral 
pigmentations in ADVIRC. The presence of retinal infiltrates and vasculitis with vitreal 
cells distinguishes acute retinal necrosis and acute multifocal hemorrhagic retinal vasculitis 
from PSR. 
In regressed retinopathy of prematurity (ROP; ICCLSROP, 1987) and dominant 
exudative vitreoretinopathy (DEVR) the areas of nonperfusion are more anterior than in 
PSR. In PSR the border perfused-nonperfused retina is highly irregular, reflecting the 
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ongoing centripetal process of vaso-occlusion; consequently, seafans are generally not 
equidistant to the disc, as is usually the case in ROP and DEVR, where vascular 
development was impaired at one point in time. Similarly, there is no V-shaped border of 
perfused retina formed by the arrested growth of superior and inferior temporal arcades as 
in DEVR. The features associated with retinopathy in incontinentia pigmenti are female 
sex, cutaneous manifestations, dental abnormalities and presentation at a generally 
younger age than PSR. 
In an aortic arch syndrome, rubeosis iridis and disk neovascularization often coexist 
and signs of severe coexistent cerebral ischemia are conspicuous. It may be required to 
perform an internal work-up in the presence of the generally discreet neovascularizations 
described in multiple sclerosis, leukemia, and sarcoid (tell tale candle-wax perivascular 
exudates may be absent). 
Arteriolitis, as described by Jampol, would appear a rare diagnosis of exclusion 
(though inactive tuberculosis was found in his case). 
The most common diagnosis of exclusion would be Eales' disease. The clinical 
definition of Eales' disease is not yet well delineated. Elliot (1975) and Renie et al. (1983), 
in series of 30 cases each, include vasculitis or periphlebitis, together with peripheral 
occlusive vascular disease, within its definition. In these authors view vasculitis would be an 
early event in the course of Eales' disease, explaining the lack of inflammatory signs in 
many patients. Spitznas (1975), however, studying over 300 patients in Essen, considered 
periphlebitis and papillitis to be part of a separate entity: idiopathic periphlebitis, and 
reserved the term Eales' disease for the non-inflammatory peripheral obstructive 
vasculopathy, that resembles sickle retinopathy in many ways. Ал important consideration 
was not to confuse the vascular sheathing (opacification of the vessel wall, hyaline 
degeneration; Michaelson, 1980), as seen in Eales' disease and sickle cell disease, with the 
more irregular and wider inflammatory sheathing known to occur in vasculitis. 
Obviously, in the diagnostic workup of each person of predominantly Negroid (or 
Mediterranean or Middle-Eastern) extraction with peripheral retinal vascular obstructions 
or neovascularization, a sickle cell test and hemoglobin electrophoresis are mandatory and 
conclusive. Any other positive finding revealed from the work-up might only suggest a joint 
pathological effect, which may be difficult to assess in terms of its relative impact. 
Interestingly, this issue has not been addressed in connection with Hb SS, Hb S-beta-thal or 
Hb SC disease. However, the combination of Hb AS and diabetes (Nagpal et al., 1977,Page 
et al., 1979), active lues, lupus erythematodes, or tuberculosis (Nagpal et al., 1977) has 
been reported in seven cases; the relative contribution of each disease to retinal 
neovascularization remains speculative. In the other reports on PSR and sickle cell trait 
patients (Rubinstein, 1967, two cases; Welch et al., 1967 and Treister et al., 1977, one case 
each), no effort was made to exclude Hb S-beta-thal-plus or other causes. 
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DIFFERENTIAL DIAGNOSIS OF PERIPHERAL RETINAL NEOVASCULARIZATION Table 10 
NON-PERFUSED RETINA DEMONSTRATED ON FLUORESCEIN ANGIOGRAPHY 
Aortic arc syndrome: 
Takayasu's disease (giant cell arteritis), 
syphilitic aortitis, atherosclerosis 
Autosomal dominant vitreorctinochoroidopathy 
Branch and central retinal vein occlusion 
Diabetes mellitus 
Dominant exudative vitreoretinopathy 
Eales disease 
Hyperviscosity syndromes; 
plasma: -macroglobulinemia 
whole blood: -chronic myeloloid leukemia 
Idiopathic occlusive arteriolar arteriolitfs 
Incontinentia pigmenti 
Long-standing retinal detachment 
Radiation retinopathy 
Retinopathy of prematurity 
Sickle cell disease (HbSC.SS.Sthal), 
Hb AS, Hb AC 7 
Tale retinopathy 
Hedges 
Goldberg 
DRSRG 1978 
1964 
1989 
van Nouhuys 19β2 
Elliot 1975 
1975;Renie 
Ashton 
Morse 
Frank 
Janipol 
Watzke 
Tolentino 
Brown 
Ben S ira 
Negpal 
; Spi tinas 
1983 
1963 
1971; 
1972 
1976 
1976 
1976 
1981 
1988 
1977, 
Moschandreou1974 
Tse 1980 
INFLAMMATION (AND NON-PERFUSED RETINA) 
Acute multifocal hemorrhagic 
retinal vasculitis 
Acute retinal necrosis syndrome 
Bfrdshot chorioretinopathy 
Multiple sclerosis 
Sarcoidosis 
Peripheral uveitis 
Toxoplasmosis 
BLunenkrantz 1968 
Wang 
Priem 
Morse 
Asdourian 
Algvere 
Duker 
Brockhurst 
Gaynon 
1983 
1988 
1975 
1975 
1970 
1988 
1960 
1984 
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PROPHYLACTIC TREATMENT OF PSR 
Hannon (1956) successfully closed retinal neovascularizations with diathermy in two sickle 
cell patients. Condon et al. (1974) used the Xenon arc for this purpose, treating both the 
feeder vessels and the seafan itself. Laser photocoagulation was initially used to treat the 
feeder vessels (Goldberg, 1971) and later used in a scatter fashion around and peripheral 
to the neovascularizations (Rednam et al., 1982) or circumferential (Cruess et al., 1983). 
Cryocoagulation has rarely administered (Lee et al., 1976). 
REPORTS 
Results and complications in the treatment series are listed in Table 11. Obviously.the 
feeder vessel technique has proven very succesful in stopping perfusion of 
neovascularizations, as shown on fluorescein angiography (Goldberg 1971c; Condon et al., 
1974; Jampol et al., 1983). 
In the combined series from Jamaica and Kingston (Jampol et al., 1983; Condon et 
al., 1984) a comparable control group is available. Within the treated group only non-sight 
reducing vitreous hemorrhages occurred significantly less frequent. Moreover, the impact 
of the choroidal neovascularizations has not yet been reported. 
The scatter technique caused few complications, but proved much less effective in 
the closure of seafans, particularly elevated ones with fibrous tissue (Rednam, 1982). 
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PROPHYLACTIC TREATMENT OF PSR Table 11 
eyes 
pat 
Hb 
X eyes 
nod 
vit hem 
ret det 
CR 
CV 
Ы 
tr 
Ьг 
eh 
χ 
f u 
Author 
Hennon 
Goldberg 
«Condon 
Lee CB 
=пшЬег of treated eyes 
=nu7t>er of patients 
=Hb type 
=percentege succesfully treated eyes 
'treatment modality : dia »diathermy 
»vitreous hemorrhage Χ E =Xenon coagulationof entire lesion 
«retinal detachment X F -Xenon coagulation of feeder vessel 
«chonoretina 
=choriovitrea 
«bleeding on 
=CV retreated 
neo L F «Lasercoegulation of feeder vessels 
neo L S «Lasercoagulation scattered 
treatment С 1 «Cryocoagulation: one freeze-thau 
cycle 
«retinal breaks С 3 «Cryocoagulation: three freeze-thau 
«choroidal ischemia cycles 
«seafans more 
«follow-up in 
year|ey|pat 
|es| 
1 '5*1 1 2 
1 '71c15|23 
1 | 2 | * 
| '74|13|11 
1 IM 
1 IM 
1 '75|10| 4 
1 1 1 2 
Goldbaun 1 '77| |20 
1 1 133 
Goldbaun 1 '79| 9| 7 
1 IM 
1 IM 
Jampol ea| 'β0| 4| 4 
Condon 
Hanscom 
Rednam 
Cruess 
Jampol 
Condon 
Kimnel 
Ι 'β0|57|43 
1 M B 
1 IM 
I '82| ¿I 4 
| '82|21| 9 
1 1 |3 
1 1 1 г 
1 I M 
| 'β3|40|23 
I 1 | 2 
1 1 1 2 
1 '83| |53 
| 'M| |34 
Ι 'β6| M 
than once treated 
months 
Hb|mod|X ey|bl|vit|ret|CR|CV|bl|tr|br|ch|x |f u| 
| | es | | hem | det | | | | I | | |mon| 
SC |dia| 2| | | I I I I I I I I 1 8 I 
SC |xen|74X | 6|-4 | 1| | | | | | |16|30 | 
Sth|Xen|70X J ) | 1 1 j 1 i I | | I 
SC |Dia|99X | 4| | 1| | | | | | | -|22 | 
ss | | || | ι ι ι ι ι ι ι | I 
sth| | I I I I I I I I I | I I 
SC ¡С 1| ¡ I | | | | | | | | -| | 
ss | | || | I I I ι I | i I | 
PSR|X F|90X | 1| | | 7| 2| 0| 1 | 9| 6| | 
PSR|L F|94X | 4| | 1| 4| B| 5| 6 |10| 5|4-30 
SC ¡С 3|99X ¡ j 1 2| I I I 1 2| ¡ -| | 
SS | | | j | j j | | | | | | | 
AS j j | | | j j j | j j | ι j 
SC |L F| ¡ j j 1| j | | 1| 4| | | j 
SC |X E|77X 1 1 8| 2|19|12| 4|31| 1| | 2| 47| 
SS | | ¡j | | | | | j | | | | 
sth| ι ι ι ι ι ι ι ι ι ι ι I I 
SC (L S|85X ¡ j j 1 j | j j j | j 4| 
SC |L S|62X | | | | | | j | | | | 111 
ss | | J l | I I I I I I I I I 
sb | j || j I I I I I I I I I 
A S ι | I I I I I I I I I I I I 
SC JLCS|27-57% I | | | | j j | | | 16| 
SS | | | | j | | j j j | | j | 
Sb | | i j j | | j | | | ι ι | 
PSR|X F|92X | | 2| -|43| M i l l i « ! 
PSR|L F|B5X 1 | -| 5| 3| | | 1 | | | 26| 
sc |L s| i| j | I 1 1 I 1 1 I 1 12| 
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REPOUTEB COMPLICATIONS AFTER PHOTOCOAGULATION OF PSR Table 12 
eyes 
Hb 
mod 
vit hem 
ret det 
CR 
CR/ CV 
CV 
m 
tr 
eh 
Author 
Condon 
= mmber of treated eyes 
= type Hb 
pat s nmber of patients 
= treatment modality : L F * Laser coagulation of feeder vessels 
= vitreous hemorrhage Χ E = Xenon coagulation of entire lesion 
= retinal detachment X F = Xenon coagulation of feeder vessels 
= chorioretinal neo 
= chorioretinal neo turned into choriovitreal neovascularization 
= choriovitreal neo 
= interval treatment to choroidal 
= CV retreated 
с choroidal ischemia 
|year|ey|pat| Hb|mod|CR| m|CR| 
M l i l i |cv| 
| '81|35|27 |SC |X E|19|19| 6| 
I I I 2 |SS | | | | | 
I I I * |sb | || | | 
Dizon-Иооге '81|21|12 |SC |L F| 41 3| 41 
I I Ι β |tC |X F| 6| 4| 2| 
I I I 1 |И |XF| l| 2| | 
neovascularization 
su - succes 
f u » follow-up in months 
m|CV| m|vit|ret|tr|su|ch|f u| 
| | |hem|det|CV| | |mon| 
|10|19| 5| 1 |10| 2| 7| 41| 
I I I 1 M 1 1 1 
I I I 1 1 1 1 1 1 
3| 4| 2| 5| 3| 6| | 9| 33| 
I I I 1 1 1 1 «1 1 
I I I 1 1 1 M l 1 
COMPLICATIONS 
Apart from the retinal breaks (Goldbaum et al., 1977,1980; Condon et al., 1980), a 
surprisingly high incidence of choroidal neovascularization has been reported after 
treatment of feeder vessels, for which high energy levels must be used to close the feeding 
artery (Table 11). In the laser-treated eyes this complication was in part prevented by the 
use of a larger spot size: i.e. 500 micrometer rather than the 50-200 micrometers initially 
used (Goldbaum et al., 1977). However, in the Xenon-treated eyes, with its relatively large 
spot-size, choroidal neovascularization remained common (Condon et al., 1984). 
Choriovitreal neovascularizations often bled and proved very difficult to close with 
photocoagulation (Condon et al, 1981; Dizon-Мооге et al., 1981). 
Due to the high energy settings used in the feeder vessel technique choroidal 
arteries can become occluded, which results in choroidal ischemia. This shows initially as 
triangular grayish-white patches anterior to the treatment site, later fading into a similarly 
shaped region of granular hyperpigmentation (Goldbaum et al., 1976). Functionally, this 
resulted in subtle changes of the peripheral visual fields only. Table 12 shows two series 
focusing on complications only. 
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COMMENT 
Previously choroidal neovascularization had been reported after laser treatment in age-
related macular degenerations (Francois et al., 1975, Benson et al., 1979) and diabetic 
retinopathy (Benson et al., 1979) and was thought to be related to focal rupture of Bruch's 
membrane. Due to the high energy settings necessary to close an artery using the feeder 
vessel technique (2,5-3 times the energy for a moderately intense burn on the adjacent 
retina, Goldbaum et al., 1977), the risk of breaking Bruch's membrane is greater than with 
the much lower energy level used in the scatter technique. 
Even with use of the highly effective feeder vessel technique, it was difficult to show 
a clinically significant effect in a prospective, randomized trial (Jampol et al., 1983; Condon 
et al., 1984). This is caused partly by the introduction of a potentially sight-threatening 
complication, such as retinal breaks or chorio-vitreal neovascularization, and partly by the 
(relative to the period of observation) slowly progressive nature of sickle cell retinopathy. 
It will certainly require a long follow-up period and a large number of patients to show a 
clinically significant effect using the less effective scatter technique. Presently, the results in 
the ongoing combined, prospective and randomised study in Chicago and Jamaica remain 
inconclusive (Goldberg, personal communication, May 1989). 
TREATMENT OF VITREOUS HEMORRHAGES AND RETINAL 
DETACHMENTS 
INTRODUCTION 
Long-standing dense vitreous hemorrhage can be treated by vitrectomy. 
Retinal detachments (tractional or rhegmatogenous, or both), sometimes associated 
with vitreous hemorrhage, must be treated either with ab externo detachment surgery 
(exoplants, encircling bands, cryocoagulation, external drainage) or with intraocular 
surgery (vitrectomy, membranectomy, internal drainage), or by a combination of these. In 
patients with sickling disorders, these operations have proven to have a high percentage of 
intra-and postoperative complications. 
Some transvitreal membranes causing tractional detachment have been treated with 
the Neodymium YAG laser (Hrisomalos et al., 1987). 
REPORTS 
Surgical procedures, outcome and complications in surgical treatment reports are 
presented in Table 14. In 14 cases, eyes lost their function (light perception (LP) positive or 
negative, hand movements only (HM). At least 67% of the reported operations were 
succesful in terms of restoring function. In two cases visual acuity was counting fingers 
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only. The remaining cases had either attached retinas or nonprogressive detachments, with 
visual acuity of 20/200 or better. 
RESULTS OF 
e x t = 
mu ж 
en « 
v l t r 
an fu = 
tran • 
ret det -
confined * 
1 
Authors | 
1 
Ryan | 
Eagle | 
Robertson| 
Ryan | 
DETACHMENT SURGERI 
e x t e r n a l approach 
r e c t u s must 
encircling 
vitrectomy 
l e des 
band 
anatomic or funct 
AND VITRECTOMY IN 
nsertion 
onal (succes) 
exchange blood transfusion 
retinal detachment 
boti 
Kear 
'71 
'73 
'75 
'75 
SeelenfreindTS 
Treister | 
Z l m | 
Jampol | 
Brazier | 
Horgan | 
Η π'sema l os 
Pulido I 
external 
vitrectomy 
combined 
total 
'77 
'81 
'82 
'86 
'87 
'87 
'88 
external approach and vi 
nmber 
PSR IV 
V eyes 
11 
19: 4 
10 
11 
34 
21 
20 
86 
1 
e x t | m u 
1 
9|4 
1|2 
4 
1 
"1 
2| 
1 
i | 
*l 
1 
" I 
1 
η 
i l 
1 
1 
5| 
34|6 
24 
201 
5516 
1 
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I 
η 
я 
я | 7 
" l 
2 | 2 
Ι ι 
M 
I 
1 5 
|10 
1 
1 3 
4| 7 
1 
I 1 
I 2 
I» 
211 
|21 
6|20 
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PSR AND COMPLICATIONS Table 
tear E ret inal tear 
ASI 
gl 
HM 
LP 
= anterior segment 
ischemia 
= secondary glaucoma 
= handnovement 
= light perception 
trectomy 
fu 
succe« 
11 
2 
10 
64 
4 
1 
3 
11 
1 
1 
1 
4 
4 
5 
4 
1 
2 
1 
1 
10 
58 
tran 
3 
14 
2 
1 
6 
5 
26 
I I I I I 
ret|tear|AS|gl|HM| 
det| |I | |LP| 
. . . . . . . . . . . . . . . . . 1 
I I 6| I 5| 
I il 1 1 
1 M i l 
4 | 4 | | | 4 | 
1 1 1 1 1 
1 M l M l 
1 1 1 i M I 
1 1 1 1 1 
1 I M I 
Ι ι 1 Ml 1| 
« I 5 | i| | | 
2 I 1 1 1 1 
1 1 1 1 1 
1 M I M I 
1 1 1 1 1 
4 4 1 1 1 
M I M I 
1 I M I 
i l I I I I 
1 
1 
| 12 | 8| | 5| 
5 | 6 | | 2| 6| 
1 « 1 3 | | 2 | 
1 
1 
6 | 13 | 1 1 | 2|13| 
14 
ANTERIOR SEGMENT ISCHEMIA 
The anterior segment ischemia syndrome (ASI) can comprise keratopathy, intraocular 
inflammation with severe pain, cataract formation and hypotony. The syndrome in its most 
severe form can lead to phtisis bulbi and enucleation. Originally it was associated with 
detachment surgery involving diathermy, detachment of rectus muscles and tight encercling 
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elements (Wilson et al., 1955; Boniuk et al., 1961; Robertson 1975) or with strabismus 
surgery on three or more muscles per eye (Girard et al., 1960). Histological studies have 
revealed necrosis of parts of iris and ciliary body (Wilson et al., 1955; Boniuk et al., 1961; 
Eagle et al., 1975) resulting from interruption of either the long posterior ciliary arteries or 
the anterior ciliary arteries. 
Ryan et al. (1975) described the syndrome in six out of nine Hb SC patients, who 
underwent detachment surgery. Since he was unable to correlate this high incidence of ASI 
consistently with the previously implicated risk factors, Ryan identified the 
hemoglobinopathy as one such factor. Obviously, any interference with blood flow and 
supply to the anterior segment can induce sickling and increase the risk of anterior segment 
ischemia. 
CLINICAL OUTCOME 
In six of the eleven reported cases with anterior segment ischemia (Table 14), vision 
worsened to hand movements or no light perception. 
COMMENT 
Even in relatively simple vitrectomies, the rate of iatrogenic breaks is rather high, which 
may be explained by the thinness of the avascular atrophic peripheral retina in patients 
with PSR (Goldberg, 1975). 
In aphakic eyes the secondary sickle glaucoma presented a problem. 
Anterior segment ischemia proved to be a major problem initially; in later series, however, 
this complication hardly ever arises. Using a hyperbaric oxygen chamber Freilich et al., 
(1977) were successful in external approach surgery without the complication of anterior 
segment ischemia. 
In contrast to the many pre- and postoperative measures suggested by Ryan et al. 
(1971) and Brazier (1986), who particularly stressed the importance of exchange 
transfusions, Morgan and co-workers (1986) used no additional preoperative steps. Their 
intra-operative complications, however, remain difficult to manage. Pulido et al. (1988) feel 
that the risk of blood transfusion exceeds its benefits. Changes in general care of these 
patients, changes in anesthesia, more sophisticated surgery in the later papers and the 
relatively small series of a heterogenous set of operations render interpretation of the 
influence of the different pre- and postoperative regimes speculative. 
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ΕΡΙΠΕΉΝΑΙ. MEMBRANES 
REPORTS 
Moriarty et al. (1987) found epiretinal membranes (ERM) in 25 eyes (22 Hb SC, 3 Hb SS 
patients) of the 699 examined eyes (3.6%). All eyes with ERMs had proliferative sickle 
retinopathy (PSR). 
Carney et al. (1987) detected epiretinal membranes in 55 of the 1486 eyes for which 
fundus photographs were available (40 Hb SC, 13 Hb SS, 2 Hb Sthal) (3.7%). The macula 
was involved in all but four eyes. In only six (Hb SS) eyes there was no coexistent PSR. In 
one eye the pucker spontaneously peeled. 
Hrisomalos et al. (1987) reported on six eyes, in which vitreous bands exerted 
traction on the retina. 
CLINICAL RELEVANCE 
In 40% percent of Moriarty's cases, visual acuity of less than 6/18 was due to the epiretinal 
membranes; in two cases poor acuity was due to tractional retinal detachment. In nine of 
Carney's cases, moderate visual loss was caused specifically by the membranes; however, 
this was not the case in six patients demonstrating severe visual loss. 
TREATMENT 
Carney et al. (1978) reported visual improvement on one case following vitrectomy and 
membrane dissection. 
Hrisomalos et al. (1987) reported usage of the Neodymium YAG laser in cutting 
vitreous bands. In three eyes, retinal traction appeared to be stabilized after treatment; in 
two of these, additional vitrectomy and membrane peeling were required. 
ETIOLOGY 
Previously vitrectomy or detachment surgery had been performed in three of 55 eyes with 
ERMs (Carney et al., 1987). 
In Carney's series there was an equal number of photocoagulated and untreated 
cases and in Hrisomanos' cases only one eye had been treated; the other five were control 
cases in treatment trials. In Moriarty's series epiretinal membranes were significantly less 
common in treated PSR eyes. 
Thus, surgery and photocoagulation cannot be implicated in the genesis of these 
membranes, but rather the presence of neovascularization with its coexistent vitreo-retinal 
changes. 
Histology from idiopathic epiretinal membranes shows predominantly glial cells 
(Clarcson et al., 1977); in proliferative vitreo retinopathy (PVR) epiretinal membranes also 
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contain fibrocytes, macrophages and retinal pigment epithelial cells (Kampik et al., 1980). 
There is no histology available of epiretinal membranes from sickle cell patients. 
Transudation of plasma from PSR lesions may disorganize the cortical vitreous; the 
resulting posterior detachment may disrupt the internal limiting membrane, thus providing 
access for glial cell ingrowth (Kampik et al., 1980) either along the retinal surface or onto 
the retracting, collapsing vitreous face, with secondary contraction of transformed retinal 
epithelial cells (Kirchhof et al., 1988). 
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CHAPTER? 
BLINDNESS IN SICKLE CELL DISEASE 
INTRODUCTION 
In this chapter we have tried to estimate the reported frequency of visual loss in sickle cell 
patients, that is due to sickle cell disease. All reported series on patients with sickle cell 
disease are listed, with, where stated, their cases of severe visual loss with probable cause 
(Table 15). 
I have paid special attention to the fact that in the papers from Jamaica series are 
reported several times, either because of follow-up or to discuss another aspect of the same 
series. The papers from Chicago mostly appear to be separate groups, drawn from a larger 
screened population (Carney et al. [1987] mentioned 769 patients screened), that has not 
been reported comprehensively. 
REPORTS 
Almost all cases of severe visual loss due to sickle cell disease occurred in HbSC patients: 
78 eyes out of 84 cases. Among HbSC patients the percentage of visual loss worse than 
20/200 in one eye is 13% and worse than counting fingers in one 11%. Fortunately, 
bilateral severe visual loss is extremelely rare. 
The complications of proliferative retinopathy i.e. vitreous hemorrhage, retinal 
detachment, epiretinal membranes and anterior segment ischemia prove to be the major 
cause of visual loss: 82% (Tables 15a and 16). 
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REPORTED SEVERE VISUAL 
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REPORTED SEVERE VISUAL LOSS IN SICKLE CELL DISEASE Table 15 
Visual Acuity 
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'86 
'86 
'87 
'87 
Hrisomalo#'87 
Kiinnel '87 
12 
4 
2 
26 
5 
162 
101 
34 
32 
3 
21 
14 
5 
1 
4 
2 
1 
13 
5 
7 
1 
1 
1 
115 
157 
25 
14 
43 
8 
6 
20 
1 
27 
2 
6 
243 
261 
59 
37 
2 
1 
17 
18 
2 
1 
9 
3 
2 
5 
4 
122 
23 
2 
2 
54 
31 
122 
1 
35 
24 
1 
12 
1 
4 
33 
11 
2 
6 
135 
SC 
SS 
Sth 
SC 
sc 
ss 
sc Sth 
sc 
Sth 
ss 
sc 
Sth 
sc 
sc 
ss 
sc 
SS opt 
sc 
sc 
SS 
AS 
sc 
SS 
sc 
Sth 
Sth 
SC 
SS 
Sth 
sc 
SS 
sc 
SS 
Sth 
sc 
SS 
SS 
sc 
sc 
SS 
SC 1 
Sbth 
sc 
SS 
sb 
AS 
sc 
PSR 
sc SS 
sb 
SS 
sc 
PSR 
SS 
SS 
sc 
sc 
SC 1 
SS 
SC 1 
SS 
Sth 
SS 
SC 
1 2 
4 8 
2 1 
1 
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REPORTED SEVERE VISUAL LOSS IN SICKLE CELL DISEASE 
Authors Year nuròer Hb Art. Sec Vttr 
TOTAL 
CAUSES OF 
Nuifcer of 
eases 
33 
42 
105 
pat. occl. si. hem. 
854 SS 9 
700 SC 4 4 24 
191 Sbthal 
1730 4 4 33 
Ret. 
Det. 
37 
42 
ASI 
5 
5 
Table 15 a 
Visual Acuity 
Both CF HM LP 0,1 
eyes 
1 1 3 4 9 
15 18 38 15 
2 
1 16 21 44 24 
VISUAL LOSS POSSIBLY DUE TO SICKLE CELL DISEASE Table 16 
Diagnosis 
ciliary artery occlusion 
macular arteriolar occlusion 
macular hole (epi.menibr.) 
optic atrophy 
secondary glaucoma 
central retinal artery 
anterior segment ischemia 
epiretinal membrane 
vitreous hemorrhage 
retinal detachment 
Nunber 
cases 
24 
16 
21 
44 
105 
of Visual Acuity 
20/200 to CF 
Counting fingers 
Hand movements 
light perception 
COMMENT 
I have ranked optic atrophy as due to sickle cell disease, (vascular impairment), which may 
be discutable. In one of Asdourian et al.'s (1976) cases lues serology was positive. 
As few of the reports clearly state severe visual loss and its cause, this compilation 
of available data represents only an estimation of visual loss related to sickle cell disease. 
The frequency of visual loss may be overestimated, because most series tended to be 
selected on symptoms or were treatment series. However, more accurate data are not 
available, as visual status is not comprehensively addressed in the larger series. 
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PARTITI 
SURVEY ON CURACAO 
CHAPTER 1 
INTRODUCTION 
Curacao is a subtropical Caribbean island, that is 40 miles long and approximately 7 miles 
wide. Over 90% of its population of 147.388 (1978 census) is concentrated around its 
capital. 
Clinical care is centered in one major 700-bed hospital and one small 40 bed facility. 
Two thirds of the deliveries take place in a separate Maternity Ward. Two independant 
laboratory services coexist. 
FREQUENCY OF Hb S AND Hb С 
Although Curacao has a multiracial community with some degree of intermarriage, 80% of 
its population is of predominently Negroe ancestry. Studies by van der Sar (1959) trace the 
area of origin to West-Africa, particularly Ghana, which would account for the high 
prevalence of the Hb С gene on Curacao. 
The prevalence of Hb AS and Hb AC on Curacao varies from 6.6-8.5 % and 5.8-
7.3% respectively (table 17). 
STUDIES 
• и 
НЬАС fi 
Author 
Jonxfs 
OF PREVALENCE OF HEMOGLOBINOPATHIES ON CURACAO Table 17 
directly observed (as opposed 
guree are used. 
I 
Nuifeer of | Genotype 
I 
|пшЬег 
screened |frequency |SS/SC 
persons |in surveys 
|HbAS|HbAC 
•59 7W|8,5X|7,3X 
вп der Sar'59 1502|6,5Х|5,8Х 
ven Zasnen '61 3097|é,6X| 
Muskiet '88 5977|2,6X| 
leases 
|SS|SC 
IMS 
|5 |6 
I I* 
|9 |8 
to calculation 
I 
| Gene 
| frequency/ 
¡10.000 
| HbS | HbC 
|0,0538|0,037V 
|0,0379|0,0309 
|0,0320| 
(0,01511 
from gene frequency) and less reliable as no HbAS or 
(for 120.000) 
[Estimated no. 
[of patients on 
|Curacao 
| HbSS|HbSC 
| 347 | 245 
| 173 | 262 
| 123 | 232* 
| 1β0*| 161* 
COMMENT 
To determine gene frequency of Hb S a sickle cell test is a useful screening method. To 
detect Hb С, however, primary electrophoresis is necessary. This was done in Jonxis' and 
van der Sar's surveys only. While Jonxis', van der Sar's and certainly Muskiet's studies 
were population screenings, van Zaanen's subjects were Shell workers, which may explain 
the lack of Hb SS patients in his series. 
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Based on gene frequency estimated numbers at birth of SS and SC patients on 
Curacao range from 123-347 and 245-282 respectively. This calculation rests upon certain 
assumptions (Hardy-Weinberg, [Vogel et al., 1986]) of random mating and no differential 
mortality between genotypes. Although interracial marriage is not rare on Curacao, Blacks 
tend to mate with Blacks. Thus, it may be more equitable to multiply gene frequency by the 
Black population only (120.000). 
In the Hb SS group the actual number will be lower due to the shorter life span of 
these patients as compared with the general population. 
The results of neonate screening show a marked decrease in gene frequency of Hb 
S, which cannot be explained by a bias in screened neonates or as a result of genetic 
counseling. The sickle-cell test used (Coli deoxygenation test) has proven ineffective in the 
detection of sickle cell trait in umbilical blood, which has a high percentage of Hb F. 
It appears a reasonable estimate that there are approximately 180 Hb SS and 240 
Hb SC patients on Curacao. 
PATIENTS AND METHODS 
RECRUITMENT 
In September 1986 all general practitioners, pediatricians, internists, gynecologists, 
ophthalmologists and surgeons were requested by letter either to provide the names of 
their sickle cell patients or to refer them for ophthalmological examination. A number of 
patients were identified from a review of hospital discharge diagnoses and by screening the 
few preserved years of electrophoresis; in some cases, their adresses were found at the City 
Hall and the Social Health Department. 
All patients, except those referred directly, were sent a letter in which the purpose 
of our study was explained in Papiamentu (the local language) and a date for examination 
was proposed. If patients did not appear a similar letter with a new appointment date was 
sent for a second and, if necessary a third time. 
When a patient's diagnosis was uncertain from his or her file, additional tests were 
ordered. 
RESULTS 
By June 1988 (the end of the survey) 81 Hb SS, 97 Hb SC, 7 Hb SF and 2 Hb S-beta-
thalassemia patients had been examined. Forty patients (primarily Hb SS patients) were 
referred by the Sickle Cell Outpatient Department, 16 by a pediatrician and two by 
ophthalmologists (Table 18). 
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Two-thirds of the patients examined participated in the study as a result of our 
written invitation. In seven instances the invitations were returned undelivered; fifty 
individuals were sent a second invitation and 40 were sent a third. 
Twenty one invited patients proved to be incorrectly listed as having either Hb SS or 
Hb SC, but to actually have Hb AS (in 19 cases), Hb AC (in one case) or Hb AA (one 
case). Fifty persons with Hb AS and Hb AA, mostly accompanying family members of the 
patients, were studied as controls. 
RECRUITMENT OF EXAMINED 
Referred 
by Sickle Cell Clinic 
by pediatrician 
by internist 
by general practitioner 
by ophthalmologist 
PATIENTS 
Nmfcer of 
patients 
37 
U 
2 
4 
г 
59 
Table 
Number of 
Invitations 
First 192 
Second 84 
Third 19 
18 
Nmfcer of 
patients 
118 
11 
-
129 
COMMENT 
Emigration may account for some of the noted discrepancy between examined patients and 
estimated numbers. From the Town Hall and the patient's family we learned that only six 
individuals lived abroad (Holland, in all cases). 
We must assume that the majority of the "missing" patients fell within several categories: 
undiagnosed cases, once diagnosed patients whose diagnoses were unavailable and who 
were not in the medical circuit at that time, invited diagnosed cases whose addresses were 
not known and invited patients who chose not to respond. 
We cannot regard all 45 non-responding individuals as missed sickle cell disease 
patients, particularly in view of the inconclusive diagnoses contained in the old listings. 
Not surprisingly, most of the patients coming from the sickle-cell outpatient 
department were Hb SS patients, as morbidity is high in this category. This group might be 
biased toward a more severe clinical course; all other recruitment lines can be regarded as 
aselective (with the exception of two cases referred by an opthalmologist and one case 
found in the laser file). 
Eventually, we managed to examine 81 Hb SS, 97 Hb SC, 7 Hb SF and 2 Hb S-beta-
thalassemia patients, which implies that the examined patients represent at least half of the 
estimated sickle cell population of Curacao. They certainly represent over 90% of known 
sickle cell patients. Even compared with the Jamaican series (Condon et al., 1972a,b,c,d), 
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the Curacao survey represents by far the most comprehensive study of ophthalmological 
findings of an entire sickle cell population. 
DIAGNOSIS 
In all reported patients diagnoses were confirmed by alkaline hemoglobin electrophoresis; 
alkali denaturation was used to quantify the percentage of Hb F. In only two cases Hb A2 
had been documented with column microchromatography. Although Hb concentration 
and hematocrit were repeatedly checked in Hb SS patients, red cell indices using a Coulter 
counter were available only from 1984 onwards. Associated beta-thalassemia had been 
diagnosed in only two cases; no diagnosis of associated alpha-thalassemia had been made; 
no endo-nuclease technique had been used. 
COMMENT 
In many of the cases studied the differential diagnosis between Hb SS, Hb S-alpha-thal, Hb 
S-beta-thal, Hb and Hb SF remains unsettled, since the diagnostic procedures as discussed 
on page 6 had not been used uniformly. We did not attempt to repeat laboratory diagnosis 
with a more complete workup, because this would have no practical impact on patient 
management. Only the patient file from the sickle cell out-patients clinic were relatively 
well kept, but even here, however, types and numbers of crisis were often difficult to 
determine. These shortcomings obviate the possibility of trying to find meaningful 
correlations between ocular findings, laboratory results and clinical course. Moreover, 
high-quality studies regarding these correlations have been performed with equivocal 
results (Hayes et al., 1981; Talbot et al., 1982,1983,1988). 
ΕΧΑΜΙΝΑΉΟΝ METHODS 
History-taking included present ophthalmologic symptoms, past ophthalmologic history, 
number and kind of admissions, obstetrical history and family history. A full 
ophthalmologic examination, including visual acuity measurement, applanation tonometry, 
slit lamp examination of conjunctiva and anterior segment, binocular indirect 
ophthalmoscopy and biomicroscopy of the vitreous and retina using a Goldmann 
contactglass, was performed in all patients, with the exception of those who were too young 
to cooperate. In these instances only binocular indirect ophthalmoscopy was used. From 
May 1987 onward, fluorescein angiography (FAG) was performed in most cases. Five cc of 
10% sodium fluorescein was injected in an antebrachial vein and a Canon 60-U 
funduscamera was used. Ilford or Kodak panchromatic 400 ASA films were used ; the film 
was developed in a commercial laboratory with Kodak D-76 for 13 minutes at a room 
temperature of 22-24 degrees Celsius. Selected negatives were printed on Dektol paper. 
For color slides we used Fuji 100 ASA. Special attention was paid to document the early 
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filling phases and the extend of capillary non-perfiision temporally. Injection of dye and 
photography were performed by the author. For a limited period a Sonometrics combined 
A and В scan was available for our use. 
5ΤΑΉ5Ή€ΑΙ. METHODS 
We used the two-tailed Fisher exact test for 2x2 tables to test whether correlations between 
examination results were statistically significant. P-values of less than 0.05 were considered 
significant. 
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CHAPTER 2 
RESULTS 
Appendix A lists the following information for the 81 Hb SS, 97 Hb SC, 7 Hb SF and 2 Hb 
S-beta-thalassemia patients studied: age, gender, type of hemoglobin, visual acuity, 
conjunctival, iris, vitreous and fundus findings (using Condon's moderate stage and 
Goldberg's classification for retinopathy). 
Such results as they apply to the 36 Hb AS and 14 Hb AA controls are shown in 
Appendix B. 
Because of the insignificant number of the Hb SF and Hb S-á-thal patients, and 
their unremarkable ocular findings, we will not discuss them under the seperate headings 
below. 
CONJUNCTIVA 
RESULTS 
The presence or absence of the conjunctival sign was noted in almost all patients. The sign 
was present in 70% of the Hb SS patients, 38% of the Hb SC patients and 25% of the Hb F 
patients; however, it was not found in any of the controls. Generally, the sign was bilateral 
and there was no correlation with intraocular complications such as proliferative sickle 
retinopathy (Table 19). 
COMMENT 
Our results correlate with those in other publications (Part II, chapter 1): the conjunctival 
sign appears more frequently in Hb SS patients than in Hb SC cases, although the 
percentages are lower. 
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THE CMJUNCTIVAL SIGN 
NS : non significant 
Total пшЬег of patients 
Conjunct ival findings noted 
Conjunctival sign present 
PSR 
present 
absent 
bilateral 
HbSS {n=77) 
Conjunctival sign 
present absent 
3 (100%) 0 
51 (69%) 23 (31%) 
P-value= 0,55006 
SS 
81 
77 
54 (70%) 
48 (89%) 
PSR 
present 
absent 
Table 19 
SC SF 
97 8 
95 8 
36 (38%) 2 
25 (69%) 1 
HbSC (n=95) 
Conjunctiva 
AS/AA 
45 
43 
0 
sign 
present absent 
19 (39%) 30 (61%) 
17 (ЗА) 29 (63%) 
P-value= 1 00000 
Figure 1. The conjunctival sign in a 36-year-Hb SS patient (case 140). 
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CHAPTERS 
IRIS 
RESULTS 
We observed iris atrophy in one Hb SS patient and in eight Hb SC patients; in only one Hb 
SC patient there was no co-existent proliferative retinopathy. The correlation between iris 
atrophy and proliferative retinopathy was statistically significant (Table 20). 
COMMENT 
Among our group of patients the percentage of patients with iris atrophy was found to be 
somewhat higher than that reported by Acheson et al. (1986)(Chapter 3) : 8% and 4 % 
respectively. Our results confirm a strong correlation between iris atrophy, Hb SC and 
proliferative retinopathy. 
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PRESENCE OF IRIS ATROPHY 
PSR : 
NS 
S : 
proliferative sickle retinopathy 
non significant 
significant 
Nunfcer 
Hb SS 
Total number of patients 81 
iris atrophy 1 
bilateral 1 
PSR 
present 
absent 
HbSS <n=81) 
Iris atrophy 
present absent 
1 (33X) 2 (67X) 
0 78 (100X) 
p= 0,03704 
of patients 
Hb SC Hb Sf Hb AS/AA 
97 
8 
6 
PSR 
present 
absent 
8 45 
HbSC (n=97) 
Iris atrophy 
present absent 
7 (UX) 42 (86X) 
1 (2X) 47 (98X) 
p= 0,05922 
Figure 2. Iris atrophy in a 52-ycar-Hb SC patient (case 120). 
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CHAPTER 4 
SECONDARY GLAUCOMA 
CASE HISTORIES 
From May 1986 to July 1988, five patients had been admitted with a traumatic hyphema, of 
which three were diagnosed to have Hb AS. The oldest patient was 26 years of age and the 
average age of this group was 13 years (table 21). 
Case 1 came only later under my care. Neither conservative treatment, nor 
trabeculectomy were successful in bringing down intra-ocular pressure. 
Only case 2 did not have a complicated course i.e. rebleeding in the anterior 
chamber or vitreous cavity. 
Case 3 did not have a hyphema on the day of trauma and had only slight peripheral 
retinal edema. The hyphema occurred on day three and had disappeared after seven days. 
Vitreous hemorrhage occurred on the fourth day and did not clear untili the end of the six-
week follow-up period. The retina appeared attached on ultrasonography. Intraocular 
pressure returned to normal after four days. 
After a failed trial of conservative treatment of case 4's "eight-ball" hyphema, a 
peripheral iridectomy proved succesful (Parrish et al., 1982). 
Case 5 presented late -- after seven days. Intraocular pressure normalized after one 
day of conservative treatment with iris dilatation, Timoptic, and Diamox; however, vision 
did not improve (Table 4). 
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CASES WITH TRAUMATIC HYPHEHATA 
Presentation : nmfcer of days after traun 
Peak Dur IOP : highest intraocular pressure and 
Fi VA 
Treb 
Per iri 
Hb 
: final Visual acuity 
: trabeculectomy 
: periphere 
: hemoelobir 
tridectony 
type 
Age/ Pres Peak Dur First Ccuplieations Sur 
Sex enta 
tion 
1 26 F 1 
2 13 M 1 
3 18 H 1 
4 5 H 1 
5 7 H 7 
IOP 
40 2 d 
34 1 d 
20 
60 2 d 
55 S d 
VA 
LP+ 
HM 
0.B 
CF 
LP-
ger 
У 
vitr.hemnorrh. trab 
rebleeding 
after 6 Heeks 
ATOO 50 rntiHg 
-
hyphema on second -
day;YÍtreous hem. 
on day four 
hyphema total on per 
day three and iri 
pressure rise to 
60 imHg 
subtotal hyphema -
some vitreous 
hemorrhage 
Table 21 
1 
its duration (days) 
Final 
fundus 
examination 
pale and 
glaucomatous di 
Fi Hb 
VA 
LP- AS 
sc, 
choroidal rupture 
around disc 
normal 
USG attached 
retina 
normal 
pale disc 
not excavated 
1.0 AS 
HM AA 
1.0 AA 
LP- AS 
COMMENT 
It is rather exceptional to have four out of five consecutive cases of traumatic hyphema run 
such a complicated course. Cases 1 and 5 presented with severe visual loss i.e. dubious light 
perception. The traumatic choroidal rupture in case 1 showed that trauma was severe and 
rupture of microvessels nourishing the optic nerve head (apart from glaucomatous 
damage) may have caused the loss of light perception. However, due to the Hb AS 
containing erythrocytes, pressure rise may have been higher and disc perfusion less 
effective. In case 5, the late presentation and the long period of pressure rise probably 
played a role in the loss of vision, but here Hb AS might be implicated with more 
probability. 
These case histories do not prove that Hb AS played a definite role in the severe 
course of two of these three Hb AS patients; however, in areas where patients with sickling 
hemoglobin live, rapid screening (sickle cell test) of a patient with hyphema appears 
warranted. Cases with sickling hemoglobin deserve expert care (Part II, chapter 2). 
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CHAPTERS 
MISCELLANEOUS FINDINGS IN THE POSTERIOR SEGMENT 
ANGIOID STREAKS 
RESULTS 
We observed angioid streaks in 5 Hb SS patients (6%). The average age of the group was 
52 years (Table 22). The angioid streaks found in these patients did not involve the macula. 
Figure 3. Angoid streaks in a 39-year-Hb SS patient (case 84). 
ANGOID 
Sex 
1 F 
2 F 
3 M 
A F 
5 F 
STREAKS 
Age Hb 
54 SS 
37 SS 
59 SS 
39 SS 
74 SS 
ь lat 
+ 
+ 
+ 
+ 
eral 
Table 22 
Total number of examined patients 
SS SC SF AS/AA 
81 97 8 45 
COMMENT 
The finding mentioned above closely corresponds with Hamilton et al's (1981) report, 
wherein angioid streaks were found in 8% of older Hb SS patients. 
65 
PERIPHERAL COLOR CHANGES 
RESULTS 
White-without-pressure was noted in three Hb SS and three Hb SC patients, as well as in 
one control (Appendix A and B). In one Hb SS, one Hb SC patient and one Hb AS patient 
there was "snail-track" peripheral degeneration; in one Hb SS patient "lattice" degeneration 
was observed. 
COMMENT 
It appears that these peripheral retinal changes are not specific for sickling disease. 
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CHAPTER 6 
NON-PROLIFERATIVE REΉNAL VASCULAR LESIONS 
RESULTS 
Tortuosity of the major vessels was conspicuous in only 5 Hb SS patients (table 23). 
Salmon patches were observed in three young patients; these were multiple and 
short-lived, as they disappeared in three weeks time (fig 4-6). 
Black sunbursts were common (i.e. in 31% of Hb SS and in 44% of Hb SC 
cases)(figure 7). Interestingly, a black sunburst was also observed in one Hb AS patient. 
We observed only one smaller vessel obstruction near the macula (Figure 8). 
Despite a large number of good quality FAG's of the posterior pole we found no evidence 
of enlarged foveal avascular zones or pathologic avascular zoes, as Nagpal et al. (1976) did. 
Neither did we observe the disc sign or major vessel occlusions. 
Figure 4. A salmon patch in an 18-year-Hb SC patient (case 150). The occluded arteriole is chalky-white. Part 
of the blow-out-, superficial-, retinal hemorrhage is hemolysed and salmon-pink. 
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Figure 5. Fluorescein angiogram of the same area as in figure 4, showing blocking of fluorescein due the 
salmon patch, and retinal capillary drop-out in the area supplied by the blocked arteriole. 
Figure 6. Fluorescein angiogram of the same area as in figures 4 and 5, showing partial reperfusion of the 
capillary bed three weeks later. 
68 
Figure 7. Black sunbursts in a 45-year-Hb SC patient (case 123). 
Figure 8. Arteriolar obstruction near the macula in a 19-year-Hb SS patient (case 37). 
69 
НСМ PROLIFERATIVE VASCULAR 
Tor : 
SP : 
IS : 
BS : 
tortuosity and d 
sal 
iri 
mon patches 
descent spots 
black sunbursts 
Age Sex Hb 
1 43 
2 11 
3 26 
4 41 
5 43 
6 21 
7 19 
a 22 
9 6 
10 42 
11 В 
12 12 
13 16 
14 24 
15 31 
16 18 
16 15 
17 7 
4 SS,1 
1 SS,1 
8 SS,3 
BLACK 
25 SS 
43 SC 
SF 
SC 
SC 
SS 
SS 
SS 
SS 
SF 
SS 
ss 
ss 
se 
se 
ss 
se 
ss 
ss 
ss 
se 
ss 
ss 
Tor 
+ 
• 
+ 
+ 
+ 
5 
SUNBURSTS 
41 
65 
eyes 
eyes 
ABNORMALITIES Table 23 
latation of major retinal arteries and veins 
SP 
4 
3 
2 
IS Total пшЬег of 
examined patients 
SS SC SF 
81 97 β 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
11 
25 total пшЬег of BS 81 
43 total nmfcer of BS 134 
COMMENT 
Most of our findings correlate with Condon and coworkers original series from Jamaica 
(1972a,b,c,d) (Part II, chapter 5). The aselective recruitment of our patients is probably 
responsable for the lack of small or major posterior pole vessel obstructions; the previously 
published cases were rare, symptomatic ones from much larger populations (Part II, 
chapter 5). 
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CHAPTER? 
PERIPHERAL RETCNOPATHY, 
PROLIFERATIVE SICKLE RETINOPATHY 
In classifying peripheral retinopathy I have combined Condon's mild and moderate stages 
for peripheral micro-angiopathy and used Goldberg's stages I to V (see Part Π, chapter 5). 
RESULTS 
Only patients under the age of 10 to 12 did not show subtle peripheral changes. 
Although numbers were small, pathology appeared mild in Hb SF patients. 
Peripheral obstruction occurred in at least 58% of the Hb SS patients and in 90% of 
the Hb SC patients. 
Neovascularization was noted in 4% of the Hb SS patients and in 52% of the Hb SC 
patients (Table 23). 
A 37-year-old Hb SC patient showed disk neovascularization, in addition to 
peripipheral neovasculatization (case 101, figure 11-12). 
PERIPHERAL CLOSURE, ARTERIOVENOUS SHUNTS ANO NEOVASCULARISATION 
FAG : fluorescein 
HbSS 
nurber of 81 (162) 
patients (eyes) 
Condon 65 (130) 
stage I 47 (84) 
stage II 22 (38) 
stage III 3 (3) 
ang 
FAG 
23 
5 
6 
10 
2 
ography 
HbSC 
97 (190) 
92 (180) 
87 (165) 
76 (136) 
50 (72) 
FAG 
50 
3 
11 
36 
HbSF 
8 
3 
2 
1 
FAG 
1 
1 
Table 24 
7 1 
Figure 9. Peripheral non-perfusion, arteriovenous anastosmoses, and retinal neovascularization in a 23-ycar-Hb 
SC patient (case 14). 
Figure 10. Seafans and a black sunburst in a 45-year-Hb SC patient (case 123) 
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Figure 11. Incipient disk neovascularization in a 37-year-old Hb SC patient (case 101). 
Figure 12. Same area as in figure 11. Later phase of the angiogram shows leakage of the disk 
neovascularization. 
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AGE DISTRIBUTION OF PSR 
RESULTS 
Hb SS patients were generally younger than patients with Hb SC. The average age was 26 
years and the median age was 24 years in the Hb SS group, as compared with 32 and 31 
years, respectively in Hb SC patients (Figures 14 and 15). 
In three Hb SS patients (two 26-year-olds and one 32-year-old) small neovascular 
lesions were observed — one dubious and two discrete. 
Figure 15 shows the higher percentage of Hb SC patients with neovascularization 
from the third decade onwards. If we consider only patients older than 20 years of age, a 
surprising figure of 71% is revealed. 
COMMENT 
The lack of retinal microvascular changes found among the children we examined is due 
partly to their reluctance to have a contact glass examination or fluorescein angiography 
performed. Using angioscopy and angiography, Talbot et al. (1982,1983,1988) found fairly 
consistent peripheral closure in the Jamaican cohort among children four years of age and 
older. Although the percentage of patients with proliferative retinopathy increases with age 
in Hb SS also (Condon et al., 1972d), and it is true that our Hb SS group is younger than 
our Hb SC group, the correlation of PSR and Hb SC remains striking. 
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Age Distribution of SS Patients 
i τ io 
0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89 
AGE 
Figure 14. Age distribution of the 81 examined Hb SS patients. 
Age Distribution of SC Patients 
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Figure 15. Age distribution of the 97 examined Hb SC patients. In addition, stages of sickle retinopathy are 
shown. 
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CHARACTERISTICS AND COURSE OF PSR 
RESULTS 
Five " infarcted-appearing " seafans (abundant glial/fibrous tissue obscuring patent vessels) 
showed varying degrees of perfusion and dye leakage on FAG. In only two cases seafans 
were proven to be nonperfused on FAG. 
In the only patient, who had dense recurrent vitreous hemorrhages during the 
survey, active, non treated lues co-existed. Although lues serology was recorded in only a 
few patients its role remains speculative, luetic vasculitis may have influenced the course of 
this patient's retinopathy. 
None of our patients with PSR was known to be diabetic; however, blood glucose 
levels were not recorded in all patients. 
Out of 50 Hb SC patients with neovascularization 18 (27 eyes) developed vitreous 
hemorrhage, at an average age of 35 years. In 13 patients (15 eyes), this had reduced vision 
to finger counting or worse at least temporarily. 
In eight patients (nine eyes) retinal detachment occurred at an average age of 38 
years. In four patients (four eyes), this had led to the loss of light perception (Table 27; 
figure 15). 
Cellophane maculopathy occurred in two patients (one 60-year-old and one 63-year-
old Hb SS) and was not related to proliferative retinopathy. It was in one 43-year-old Hb 
SC with a vitreous hemorrhage; a more pronounced epiretinal membrane occurred in a 34-
year-old and a 36-year-old Hb SC after vitrectomy. 
COMMENT 
Obviously, retrospective analysis of cases with complications provides a biased view on the 
natural history of PSR. Chances are that patients who had experienced symptomatic 
vitreous hemorrhage or retinal detachment were more likely to want to participate in our 
study. Moreover, one patient's name (case 183) would not even have been known to me, 
had he not presented with a dense vitreous hemorrhage. Thus, figures we have gathered 
with respect to Hb SC patients with symptomatic vitreous hemmorrhage or retinal 
detachment may be too high. 
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However, in the absence of prospective long-term longitudinal observations (those 
the Jamaican cohort have not yet reached the age at which PSR can occur) retrospective 
analysis may be of value. Because complications such as vitreal hemorrhage or retinal 
detachment tended to occur over a wide age range (23 to 51 year old), we can only study 
the course of PSR per case and not per group affected by either complication. Retinal 
detachment tended to follow vitreous hemorrhage within half a year. This may indicate that 
once significant vitreous traction develops, it may cause both hemorrhage from the already 
present seafans or detachment of the retina. 
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Figure 16-17. Auto-infarcted seafan in a 53-year-old Hb SC patient (case 120). No perfusion on FAG. 
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Figure 18-19. Fibrotic, "involuted-appearing" seafan proved to bc well perfused on fluorescein angiography, in a 
31-year-old Hb SC patient (case 169). 
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CHAPTERS 
VISUAL LOSS DUE TO SICKLE CELL DISEASE 
Six out of the seven patients (nine eyes) with visual acuity of 0.1 or worse due to sickle cell 
disease at the time of examination, had Hb SC and proliferative sickle retinopathy. 
One patient (case 15) with Hb SS had severe circulatory shock and respiratory 
arrest, due to intra-abdominal blood loss following a cholecystectomy, which resulted in 
bilateral cortical blindness; patient 74 is the only other person with bilateral severe visual 
loss entirely due to sickle cell disease: no light perception in his right eye due to total 
retinal detachment, and visual acuity of 0.1 in OS due to a macular hole with an epiretinal 
membrane and partial retinal detachment. 
Thus, the percentage of severe visual loss in one eye due to sickle cell disease 
among the entire study population is 5% (visual acuity of 0.1 or worse) or 4% (visual acuity 
of counting fingers or worse). In Hb SC patients, however, these percentages are higher: 7 
% and 6 % respectively (Table 26 and 27). 
DECREASED 
VA 
>0.1<0.8 
0.1 
CF 
HM 
NLP 
VISION IN 
nunber 
of eyes 
19 
A 
3 
2 
6 
ЗА 
81 Hb SS and 97 Nb SC PATIENTS 
due 
PSR 
H 
to due to 
sickling 
г 
2 
other 
cause 
12 
3 
2 
1 
18 
HbSC 
13 
A 
3 
2 
A 
26 
HbSS 
6 
2 
a 
Table 26 
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CASES WITH VISION LESS 
DETACHMENT Table 
Hb 
А С 
Con 
lo VA 
Case 
Sex 
15 F 
34 F 
59 F 
74 M 
86 F 
89 M 
90 M 
96 M 
123 M 
137 M 
138 M 
144 F 
147 F 
149 F 
166 M 
172 M 
175 M 
176 M 
183 M 
; 
: 
: 
: 
type Hb 
age at uhi 
27 
ch с 
CMpHcation 
lowest visual 
THAN 1/10 RELATED TO SICKLING DISEASE OR WITH VITREOUS HEMORRHAGE OR RETINAL 
RO 
Duplications occurred VH 
CVA 
acuìty 
: retinal detachment 
: vitreous hemorrhage 
: cerebrovascular 
accident 
Age Hb A Corn Lo Course Final Present 
с 
28 SS 16 CVA 
52 
40 
SC 37 RD 
40 VH 
SC 40 VH 
58 SC 39 RD 
53 VH 
57 RD 
30 SC 26 VH 
34 
28 VH 
SC 23 VH 
24 RD 
28 SC 28 VH 
42 
45 
25 
51 
45 
41 
42 
40 
36 
34 
73 
51 
28 VH 
SC 35 VH 
39 RD 
SC 36 RD 
SC 23 VH 
24 VH 
SC 42 VH 
SC 42 VH 
SC 40 VH 
SC 36 VH 
SC 34 VH 
SC 29 VH 
34 VH 
RD 
SC 27 VH 
RD 
SC ? VH 
SC 51 VH 
VA 
NLP 
NLP 
NLP 
no inprovement 
cortical blirrtiess 
two unsuccesful 
buckling procedures 
0.6 Xenon (Boston) 
0.6 
NLP 
0.1 
CF 
CF 
NLP 
1.0 
1.0 
CF 
0.1 
NLP 
HM 
HM 
0.2 
CF 
1.0 
CF 
0.3 
0.4 
HM 
CF 
CF 
HM 
laser (Miami) 
unsuccesful buckling 
VA findings 
NLP fundi 
NLP normal 
NLP total RD on USG 
mature cataract 
0.6 pseudophakos 
1.0 non-perfused fans 
NLP total RG on USG 
procedure,no docunentat ι on mature cataract 
(Bogota) 
cleared spontaneously 
asymptomatic RD; (Miami) 
RD surrounded by laser 
VI trectomy, lensectomy 
» , " (Miami) 
laser (Rotterdam) 
unsuccesful vitrectomy 
(Nijmegen) 
asymptomatic,not treated 
U 11 
plus mature cataract 
vi trectomy, lensectomy 
buckle.vitrectomy,lens-
ectoiiiy(Bogota) 
7 
scatter laser (Curacao) 
rebleeding 
laser 
scatter laser,rebleeding 
feeder vessel(Curacao) 
scatter laser(Curacao) 
laser 
leser(Hijmegen) 
vi trectomy, lensectomy, 
buckle(Miami) 
vitrectomy,lensectomy 
(Nijmegen) 
vitrectomy (Miami) 
recent presentation 
0.1 lamellar macular 
hole 
1.0 non-perfused fans 
1.0 
NLP total RD on USG 
phtieis bulbi 
1.0 
1.0 
0.8 fresh VH 
0.6 retina attached 
NLP total RD on USG 
; cataract 
0.2 retina attached; 
0.2 lues II 
1.0 nonperfused fans 
0.8 local RD,empty fan 
1.0 still perfused fan 
0.4 empty fan.cellopti. 
1.0 non-perfused fans 
0.9 fibrosed ridge 
with traction 
0.7 attached retina 
cellophane 
0.4 epiretinal membrane 
CF cataract 
HM retina attached on USG 
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PATIENTS WITH VISUAL LOSS DUE TO OTHER CAUSES Table 28 
Case 
5 
9 
39 
71 
100 
103 
109 
111 
126 
138 
176 
183 
Eye 
00 
00 
OS 
OS 
OS 
CO 
00 
OS 
00 
OS 
CO 
OS 
OS 
00 
00 
OS 
OS 
Visual Cause 
ACUÌ 
0.1 
0.3 
0.6 
0.6 
0.3 
0.2 
0.6 
0.6 
m 
0.1 
0.3 
0.3 
0.6 
0.4 
0.2 
0.1 
0.6 
ty 
amblyopia due to unilateral nyopia (S-16)) 
anblyopia due to hypermetropic astygmatisn 00 
myopic astygmatism and lack of cooperation 
secondary cataract in Pseudophakie 
aufclyopia due to unilateral myopia (S-9) 
amblyopia due to divergent strabismus 
no optimal refraction 
H η 
mature cataract 
dense cataract 
secondary cataract 
cystold macular edema 
incipient stixapsular posterior cataract 
anblyopia due to іжііlateral high myopia end divergent 
dense nuclear cataract 
mature cataract 
anterior polar cataract 
strabismus 
VISUAL LOSS DUE TO OTHER CAUSES 
In two cases mature cataract prevented fundoscopy; though ultrasonography was not 
available at the time of examination of those patients, we assumed their retina was 
attached because light projection and gross color vision were intact. They are grouped 
under "other causes" (Table 28). Most of these patients showed moderate visual loss. 
COMMENT 
Severe visual loss due to sickle cell disease occurs somewhat less frequently than has been 
reported in previous publications (Part II, Chapter 7). This is understandable, as many of 
these were treatment series, whereas our series was probably the most aselective one. It 
has been shown that proliferative sickle retinopathy in Hb SC patients is the major cause of 
severe visual loss. 
Although the extent of neovascularization is often limited and progression to 
vitreous hemorrhage, retinal detchment and severe visual loss is not the rule, a 
considerable portion of these patients did get vitreous hemorrhage (36%) or retinal 
detachment (14%). The loss of sight and phtisis bulbi in four eyes in relatively young 
patients, in a closely defined population (Hb SC, over 18 years of age) should prompt us to 
find ways, that could prevent this from occurring. 
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CHAPTER 9 
TREATMENT 
INTRODUCTION 
Table 27 shows the range of treatments, which had been administered abroad to the 
patients I have examined: cryo, xenon, laser, buckling procedures and vitrectomies (as 
discussed in chapter 6, part II). Though this survey was not intended as a treatment study, 
our own experience with laser treatment will be briefly discussed. 
PATIENTS AND METHODS 
I have either advised or administered treatment to patients with previous vitreous 
hemorrhage or large seafans ( >30 degrees). 
In all cases 500 micrometer bums of moderate intensity (typical setting: 150-200 
milliwatts, 0.2-0.5 second) were placed approximately 500 micrometers apart three to five 
rows peripheral to the seafan in the avascular retina and two rows centrally to it, while 
extending half a clock hour both ways from the seafan (scatter technique; Rednam et al., 
1982). We were careful not to place more than 140-160 spots during one session, so as to 
avoid increasing existing vitreous traction. Generally, we would treat patients over the 
course of several sessions. 
In patient 144, we used the feeder vessel technique to treat an elevated fan with 
vitreous traction, which had caused a dense vitreous hemorrhage previously. The feeding 
artery was closed by 100 micrometer spots, carefully calibrated to have 2-2.5 times the 
intensity that would cause a moderate retinal burn (Jampol et al., 1977). 
A Coherent Argon blue-green laser was used. 
RESULTS 
Although in my own hands the scatter technique resulted in no complications, it was often 
only partially or not effective (Figure 22); in only eight out of 17 eyes (13 patients), vessel 
closure confirmed by fluorescein angiography was achieved. Compliance with advised 
(additional) treatment sessions was often low, as was compliance with follow-up. 
Application of the feeder vessel technique was effective in case 144 (figure 20-21). 
However, this technique had caused choroidal neovascularization in one of the previously 
treated patients (case 39). 
In most cases, that had been treated with photocoagulation only in the past 
(abroad), treatment had been succesful. However, prognosis was more guarded in eyes that 
had required buckling procedures or vitrectomy. 
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Figure 20. Large, elevated seafan, which had caused a dense vitreous hemorrhage previously, in a 45-year-old 
Hb WSC patient (case 144). Previous scatter treatment had not been successful. 
Figure 21. Successful closure of the feeder arteriole (feeder vessel technique). The smaller neovascularisation 
has not been treated with this technique. 
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TREATMENT OF PSR 
* 
# 
ПС no 
contolned 
PATIENTS ranged according to increasing 
size of seafans Table 29 
with surgery abroad 1 
photocoagulation performed abroad 
control 
at advised treatment 
fu follo« up 
Hb Patient 
SC 43 
SC 90 
SC 20 
SC «1 
SC 184 
SC 169 
SC 175 
SC 163 
SC 34 
SC 101 
SC 129 
SC H 
SC H 7 
SC 138 
SC К З 
SC 73 
sc 61 
SC 157 
SC 59 
SC 137 
SC 89 
SC H 4 
SC 123 
SC 160 
SC 96 
SC 174 
SC 74 
SC 86 
SC 166 
SC 172 
SC 149 
SC 54 
SC 39 
N D 
R К 
R С 
R D 
E UT 
R V 
R U 
И S 
И DU 
A H 
D N 
Ε В 
I R 
Ρ Ρ 
R Ρ 
С JN 
E I 
F S 
A H 
Ε Ρ 
К К 
G R 
S И 
E S 
E И 
R W 
H J 
G К 
S Τ 
E W 
E R 
E G 
A DU 
Degrees 
neo 
00/OS 
10/20 
20/20 
30/5 
30/10 
30/15 
30/30 
30/* 
40/0 
45/0 
30/45 
45/30 
0/60 
0/60 
0/60 
0/60 
60/0 
60/0 
10/60 
30/60 
60/60 
60/+ 
45/90 
120/+ 
90/60 
90/90 
90/90 
•/120 
120/120 
120/120 
120/200 
180/40 
220/220 
+/180 
Laser 
OO/OS 
+/+ 
-
-
•/-
-
-
+/* 
+ 
•1* 
-/• 
·/* 
-/• 
• / # 
•/+ 
#/* 
•/+ 
-/* 
+/+ 
*/-
+1-
*/# 
*/* 
#/# 
"/* 
»/-
+/+ 
*/# 
Result 
closed 
neat 
neat 
closed 
ncc 
ncfu 
closed/* 
leakage 
ncfu 
ncat/DNV closed 
net 
net 
leakage 
closed 
leakage 
ncfu 
neat 
neat 
net, progression, lues 
net/closed 
net 
almost closed 
later lasered abroad 
ncfu 
Hailed off retinal detachment 
nfu 
closed/neat 
almost closed 
choroidal neo 
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COMMENT 
Unfortunately, a comprehensive evaluation of treatment did not prove feasible due to a 
high rate of non-compliance with either advised therapy, continuation of such therapy or 
follow-up with fluorescein angiograms. Obviously, in this set-up we are unable to present a 
solid argument for or against laser treatment in PSR (Part II, Chapter 6). 
Personally, however, I believe that careful application of the scatter technique (but 
more extensive than in figure 22, if necessary in multiple sessions), and, in some cases, of 
the feeder vessel technique, is indicated in eyes at risk (i.e. those with more than 30 or 45 
degrees neovascularization or whose neovascularization had produced hemorrhage). 
Figure 22. Despite a fair amount of scatter laser coagulations, this seafan remained perfused, in a 41-year-old 
Hb SC patient (case 147). 
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PART IV 
In this chapter we will present data from our survey relating to fields which have not yet 
been reported in the literature. 
CHAPTER 1 
THE VITREOUS IN SICKLE CELL PATIENTS 
INTRODUCTION 
Though proliferative sickle cell retinopathy, which has complications such as vitreous 
hemorrhage and tractional retinal detachment, has been extensively studied, vitreous 
involvement has received little attention. Ryan (1975) discussed its possible role in 
proliferative sickle retinopathy and Paylor and coworkers (1986), using fluorophotometry, 
found an increased vitreal conductivity only in patients with proliferative retinopathy. 
During our survey we carefully noted vitreous findings. 
PATIENTS AND METHODS 
We used a Goldmann three-mirror contact lens for examination of the vitreous. Synchysis 
we defined as cavities in the vitreous gel; complete posterior vitreous detachment when the 
vitreous had collapsed forward and was seen seperate from the posterior retina upward to 
the superior vitreous base. 
We used the chi-square test to test for statistical significance of a correlation 
between the presence of synchysis or posterior vitreous detachment and stage III, IV or V 
retinopathy. In a covariant analysis we corrected for age. We considered p-values of 0.05 
significant. 
RESULTS 
In about 75% of Hb SS and SC patients and 45% of controls we have examined the 
vitreous carefully (Table 29). Common reasons for not performing this part of the 
examination were: patient either too young or unwilling to cooperate, or because of 
subsequent fundus photography. 
Synchysis occurred in 30% of Hb SS and 57% of Hb SC patients examined. 
Posterior vitreous detachment occurred in 3 (5%) of Hb SS patients and 20 (29%) of Hb 
SC patients. In only three patients there was no PSR. 
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Both synchysis and posterior vitreous detachment had a significant correlation (P: 0,056) 
with proliferative retinopathy (stage III) in Hb SC patients (Table 30). The frequency of 
synchysis or posterior vitreous detachment did not increase statistically significantly in the 
consecutive stages of PSR (stages III, IV and V)(Figure 23). Neither was there a 
statistically significant difference between age and vitreous changes within stages ΠΙ, IV 
and V. The few patients with local subhyeloid hemorrhages represent the "normals" in 
stage IV (figure 23). 
PATIENTS WHO HAD VITREOUS EXAMINATION PERFORMED 
PSR : proliferative sickle retinopathy 
NS : non-significant 
S : significant 
bilateral cases betueen brackets 
Total nmber of patients 
Vitreous examination 
No abnormalities 
Synchysis 
Posterior vitreous 
detachment 
SS 
81 
60 
39 
18 (H) 
3 ( 3) 
sc 
97 
70 
30 
го (15) 
го (is) 
SF 
а 
6 
4 
2 
Table 
AA 
45 
20 
18 
2 
29 
PSR 
I SS 
ι 
I 
1 
I 
1 
1 
| 
I 
I 
I 1 
1 1 I 
SC 
49 
40 
β 
15 (13) 
17 (15) 
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RESULTS OF VITREOUS EXAMINATION 
PSR 
present 
absent 
PSR 
present 
absent 
Hb SC (n=70) 
PVD 
present absent 
17 3 
3 47 
P-value= <0,00001 
Hb SC (ГР50) 
Synchysfs alone (PVD ex« 
present absent 
15 8 
5 22 
P-value« 0,00128 
PSR 
present 
absent 
P-value= 
luded) 
Table 30 
Hb SC <n=70) 
Synchysis or PVD 
present absent 
32 8 
8 22 
ο,υουοι 
Vitreous State Distribution 
Within Each Stage of Sickle Retinopathy 
for Hb SC Patients 
100% 
75% 
50% 
25% 
0%'— 
STAGE Ml STAGE III STAGE IV STAGE V 
I H Normal H i Synchysis ' , Vitreous Detachment 
Figure 23. Vitreous findings within the different stages of sickle cell retinopathy. 
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COMMENT 
Hypothetically, traction of the vitreous on a vessel wall might possibly influence 
angiogenesis by vessel stretch (Stefannson et al., 1983), as a suture provoked some 
microscopical evidence of angiogenesis in an animal model (Kumayama et al., 1988). In 
addition, Davis (1966) observed in proliferative diabetic retinopathy, that the retracting 
posterior vitreous face initiated preretinal extension (scaffold function), and that traction 
on the fibrovascular fronts caused vitreous hemorrhage and tractional retinal detachment. 
MacMeel et al. (1987) suggested a similar mechanism in proliferative sickle cell 
retinopathy; however, due to traction on the atrophic peripheral retina rhegmatogenous 
retinal detachment is more apt to occur. 
Vitreous degeneration may be accelerated in proliferative sickle retinopathy due to 
partial breakdown of the blood-retina barrier (Paylor et al., 1986), possibly by oozing of 
plasma constituents (Ryan, 1975). 
We found a manifold greater frequency of synchysis in Hb SS and Hb SC patients 
and posterior vitreous detachment in Hb SC patients than we would expect in normal eyes 
in this relatively young age group (Foos et al., 1982). Our finding of a significant 
association between both syneresis and PVD in all stages of PSR confirms that vitreous 
degeneration occurs in proliferative sickle retinopathy. As synchysis also occurred in young 
patients without proliferative retinopathy, early vitreous changes may accompany mild 
retinopathy as well. 
It appears logical to presume that these vitreous changes are secondary to the 
break-down of the blood-retina barrier as present in sickle cell patients. However, the lack 
of longitudinal observations and the lack of difference in age of patients with vitreous 
detachment in relation to the different stages of PSR preclude any conclusion on 
vitreoretinal interaction. 
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CHAPTER 2 
CHOROIDAL FILLING PATTERNS IN SICKLE CELL PATIENTS 
INTRODUCTION 
Despite the significantly impaired rheology in both Hb SS and Hb SC patients, only 
three cases of ciliary artery occlusion (Condon et al., 1973; Dizon et al., 1979) and only one 
case with choroidal arteriolar occlusion (Condon et al., 1973) have been reported in sickle 
cell patients. 
Either twod (Saracco et al., 1984; Yoneya et al., 1987) between the choroidal 
arteries. However, Hayreh (1975), using fluorescein angiography after posterior ciliary 
artery ligation in primates, maintained that, in vivo, no functional anastosmoses occur. On 
fluorescein angiograms, he recognized a vertical watershed zone between the two posterior 
ciliary arteries, as well as nine areas in the posterior pole, supplied by separate short 
temporal ciliary arteries. From the numerous choroidal arteries, precapillary arterioles 
(20-40 micrometers, without sphincter) run forward to the choriocapillary subunit (a 
polygonal lobule, 450 micrometer in size), which has a central arteriole and peripheral 
collecting venules. From these venules larger venae form, which drain into the vortex 
ampullae. 
There are two well-recognised forms of choroidal ischemia, i.e. ciliary artery 
occlusions, causing the triangular syndrome in its acute or late stage (Amalric 1963,1971; 
Foulds et al., 1971), and choroidal arteriolar obstructions, in e.g. accelerated hypertension 
(Morse, 1968), toxemia of pregnancy (Fastenberg et al., 1980), thrombotic 
thrombocytopenic purpura (Stefani et al., 1978) and acute posterior multifocal placoid 
pigmentepitheliopathy (Deutman et al., 1978), in which there may be multifocal 
opacification of the outer retina and serous detachment of the sensory retina. Choroidal 
ischemia can often be asymptomatic, and even severe ischemia can occur without leaving 
permanent changes of the pigment-epithelium or sensory retina (Gaudric et al., 1982). 
Despite the significantly impaired rheology in both Hb SS and Hb SC patients, only 
three cases of spontaneous ciliary artery occlusion (Condon et al., 1973; Dizon et al., 1979) 
and only one case with choroidal arteriolar occlusion (Condon et al., 1973) have been 
reported in sickle cell patients. 
We speculated, however, that more subtle changes in filling of the choriocapillaris 
might be common in sickling patients. During the course of this survey, we paid special 
attention to the early phase of fluorescein angiograms. 
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ΡΑΉΕΝΤ8 AND METHODS 
We obtained good quality, early arteriovenous phase fluorescein angiograms (FAG) 
in 51 Hb SS or Hb SC patients and 16 controls (5 Hb AS, 11 Hb AA) of matched age and 
race. 
We classified choriocapillary areas that had not filled in the early arteriovenous 
phase according to their location - adjacent to the disc, - watershed zone or — adjacent to 
the macula in geographic patterns reminiscent of the areas supposedly supplied by the 
various tees (Hayreh, 1975). 
We performed the Fisher exact test to determine whether the correlation between 
the presence of sickle cell disease and the occurrence of an uneven filling pattern had 
statistical significance. We considered a P-value of 0.05 significant. 
RESULTS 
We did not find evidence of either ciliary artery occlusion or arteriolar occlusion in our 
entire study population (97 Hb SC patients, 81 Hb SS). 
Choriocapillaris filling was not uniform in the early arteriovenous phase in more 
than half (55%) of the Hb SS patients and in three quarter of the Hb SC patients. Two Hb 
SS and four Hb SC patients showed a combination of late filling of either disc or watershed 
zone in combination with geographic defects (Table 31; Figures 24-25). 
Surprisingly, only three controls did not show similar uneven filling patterns (Table 
31; Figure 26-28). There was no significant difference in the frequency of early 
choriocapillaris filling pattern between patients with Hb SC or Hb SS and the controls (Xi-
square,P= 0.18). 
In only Hb SS and two Hb SC patients the uneven choriocapillaris filling pattern 
remained visible into the venous phase of the angiograms. 
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Figure 24. Late filling in a geographic pattern, in a 36-year-old Hb SC patient (Case 69). 
Figure 25. Late filling in a geographic pattern, in combination with a pronounced watershed zone, in a 43-year-
old Hb SS patient (Case 117). 
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Figure 26. Late filling mostly in a geographic pattern adjacent to the macula, in a 23-year-old Hb SC patient 
(Case 153). 
Figure 27. Late filling in a geographic pattern, merging with the watershed zone, in a 24-year-old Hb AS 
control (Control 36).-
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Figure 28. Late filling in a geographic pattern, in a 48-year-old Hb AA control (Control 12). 
EARLY ARTERIOVENOUS PHASE CHOROIDAL FILLING 
Table 31 
NS : non-s igni f leant 
FAG with early av phase 
1- adjacent to the disc or 
watershed area 
2- adjacent to the macula 
in geographic "short ciliary 
artery pattern " 
3- combination of both of the above 
4- even filling of choriocapillaris 
SS 
22 
2 
4 
4 
12 
22 
PATTERNS 
SC 
36 
3 
19 
5 
9 
36 
ON FLUORESCEIN ANGIOGRAPHY. 
AS 
5 
1 
2 
2 
5 
J 
AA 
11 
9 
1 
1 
11 
Choroidal pattern 
1, 2 or 3 
Present 
Absent 
Hb SS/SC 
Present 
32 
26 
Absent 
13 
3 
74 patients 
(NS) 
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COMMENT 
Because the diameter of choroidal capillaries is relatively large compared with that 
of retinal ones, and choroidal flow velocity is high, obstruction due to intracellular sickling 
of erythrocytes may be less likely to occur in the choroid than in the retina. Moreover, 
deoxygenation of hemoglobin S, which provokes sickling, will be less common in the 
choroidal circulation with its high venous oxygen saturation. 
There are few reports on the occurrence of ciliary artery occlusion (three cases 
[Condon et al., 1973; Dizon et al., 1979]) or choroidal arteriolar obstruction (one case 
[Condon et al, 1973]). Nor did we find evidence of these events in our entire study group. 
The significance of more subtle temporary filling defects of the choriocapìllaris 
during fluorescein angiography, either representing the watershed zones or geographic 
areas, remains controversial. Oosterhuis et al. (1971) and Shimizu et al. (1973), using 
sequential angiograms, considered these filling defects physiological; however, they did not 
specify for which phases of the angiogram. Richard et al. (1988), using video-angiography, 
maintained that uneven choriocapillary filling after the early arteriovenous phase was 
pathological. 
Generally, filling of the choriocapìllaris should be completed as the retinal veins begin to 
fill (DeLaey, 1983; Hayreh, 1988, personal communication). Delayed filling of some areas 
at that time could be due either to a relative obstruction of blood flow to these lobules, or 
to an anatomic variation in vessel length or lumen. Current imaging techniques are unable 
to distinguish between the two. 
Initially, we speculated that the uneven filling of the choriocapìllaris in the early 
arteriovenous phase in our sickle cell patients could be a sensitive sign of their impaired 
rheology. However, we later found the same patterns in matched Hb AS and Hb AA 
controls. 
In conclusion, we found no difference in choroidal filling pattern between sickle cell 
patients and controls; consequently, at least in Blacks, a delayed filling pattern of the 
choriocapìllaris in the early arteriovenous phase only cannot be regarded as pathologic. We 
may be able to gain specificity by evaluating the choroidal filling in a later stage of the 
angiograms. 
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CHAPTER 3 
RELATION BETWEEN PERIPHERAL CLOSURE AND PROLIFERATIVE 
RETINOPATHY IN SICKLE CELL DISEASE 
INTRODUCTION 
Although proliferative sickle retinopathy (PSR) clearly occurs more frequently in Hb SC 
than it does in Hb SS disease, the frequency of peripheral retinal obstructions has been 
reported as essentially similar in both genotypes (Condon et al., 1972a,b). In fact, in the 
Jamaican cohort study, Hb SS children, currently up to the age of 12 years old (Talbot et 
al., 1988) show more peripheral closure than SC patients. 
In contrast, however, in our cases we found more peripheral closure in Hb SC 
patients, which appeared related to the high incidence of PSR in these patients. Therefore 
we made an attempt to quantify the area of nonperfusion temporally and to relate these 
data to the occurrence of neovascularizations. 
METHODS 
We prepared composite fundus photographs of all patients whose fluorescein angiograms 
were adequate for this purpose. Magnification was uniform in all pictures. None of the 
patients studied had anisometropia greater than two diopters. In masked fashion, we 
measured two distances: from the mid-temporal disc margin to the temporal border of 
perfused and nonperfused retina through the fovea, and the minimal distance from the disk 
to the non-perfused retina. The numeric t-test was performed to determine whether 
measurements of either distance were significantly different between Hb SS and Hb SC 
patients, as well as between those with and without neovascularization. We adjusted for age 
with covariant analysis. P-values of 0,05 or less were considered significant. 
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RESULTS 
In our study PSR was found to be common (52%) in HB SC patients and rare in HbSS 
cases (4%). We were able to produce a composite fluorescein angiogram of 15 Hb SS and 
36 Hb SC patients (Table 32)(Figures 31-34). 
After adjusting for age, measurements of both distances were significantly (P< 
0.0001) smaller in the presence of retinal neovascularization. Measurements of both 
distances were also significantly (P< 0,0001) smaller in Hb SC patients (Figures 30-31). 
The average and median ages of these Hb SS patients were not lower than those of the Hb 
SC patients. In both groups most patients had stage II or ΠΙ sickle retinopathy (Table 32). 
One Hb SC patient (case 101), whose measurements were indicitative of large 
nonperfused areas, showed both disc neovascularization and peripheral neovascularization. 
His blood sugar levels were consistently normal. 
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Figure 31. Composite FAG in a 37-ycar-old Hb SS patient (Case 49). Areas of nonperfusion in the far 
periphery are not visible on this FAG. Stage I sickle retinopathy. Note the black sunburst. 
Figure 32. Composite FAG in a 21-year-old Hb SC patient with marked nonperfusion (Case 154). Stage II 
sickle retinopathy. 
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Figure 33. Composite FAG of a 18-year-old Hb SC patient (Case 143) with marked nonperfusion and 
neovascularization in this eye, which is not in view. Stage III sickle retinopathy. Note two black sunbursts. 
Figure 34. Composite FAG of a 26-year-old Hb SC patient with retinal neovascularization. Stage III sickle 
retinopathy. 
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COMMENT 
We would have preferred to have quantitative measurements of nonperfused retina; 
however, it would have been impossible to assess the peripheral border of the nonperfused 
retina (i.e. the area reaching up to the ora serrata). A computerized morphometric area 
reading of the perfused temporal retina could be considered as an alternative; however, as 
this method was not available to us, we arbitrarily chose two easily reproducible distance 
readings from the disk to the temporal border of the perfused retina. Although the 
minimum distance reading takes into account some of the irregularity of this border, our 
method remains a semi-quantative measure at best. 
Several theories have been suggested to explain why proliferative disease so 
frequently occurs in Hb SC patients, whereas in all other organs vaso-occlusive tendency is 
greater and the clinical course is more severe in Hb SS patients. BE Serjeant et al. (1984) 
and GR Serjeant (1985) believed that there is a higher rate of autoinfarction in budding 
neovascular tissue due to a high vaso-occlusive tendency in Hb SS disease; alternatively, a 
vasostimulatory factor is not produced by the nonperfused retina in Hb SS patients because 
it is more hypoxic than the nonperfused retina of Hb SC patients. 
Our results show a greater vaso-occlusive tendency in the retina of Hb SC patients 
as compared with HbSS patients; the subsequently larger nonperfused areas provide a 
stronger stimulus for new vessel formation, which explains its high incidence in Hb SC 
disease. In the other five cases of disc neovascularization in sickle cell patients (all Hb SC), 
the ischemic area may also have been exceptionally extended, as was the case in our 
patient. This explanation appears straightforward and in accordance with the current 
concept of retinal neovascularization: an angiogenesis-stimulating balance of modulating 
factors, elaborated by ischemic retina. In addition, it is comparable with the finding in 
diabetics that more extensive nonperfusion causes more severe neovascularization 
(Shimizu et al., 1982). 
Though bias may have entered in the selection of the two groups studied by us, we 
do not believe this affects the conclusions drawn from their analysis, as we have included 
age (the only known factor to affect peripheral nonperfusion in sickle cell patients) as a 
possibly confounding factor in this analysis. Our findings are in good correlation with 
recent work concerning sickle cell patients, where the amount of ERG amplitude reduction 
was found to be related with the extend of peripheral retinal non-perfusion (Gagliano et 
al., 1989). 
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Since retinal vaso-occlusive tendency is more pronounced in Hb SS patients up till 
12 years old (Talbot et al., 1988) and the occurrence of PSR begins to increase in young 
adult Hb SC patients, (Condon et al., 1980), it follows that the more extensive nonperfused 
areas observed in our Hb SC patients must develop when they are between 12 and 20 years 
of age. 
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CHAPTER 4 
RETINAL AUTOREGULATION IN SICKLE CELL PATIENTS 
INTRODUCTION 
The variability in clinical severity within a group of patients with the same type of 
hemoglobinopathy (i.e. Hb SS.Hb SC) is not well explained by known hematological, 
biochemical or rheological findings, which focus primarily on intravascular pathology. 
There is evidence that micro-vascular adaptation mechanisms occur in sickle cell 
patients, which may play a role in the clinical course (Rodgers et al., 1984). 
In healthy subjects retinal vessels are reported to constrict after the breathing of 
pure oxygen (Sicker et al., 1953). This autoregulation gets impaired with age, hypertension 
and diabetes, particularly when the retina is ischemic (Hickam et al., 1960; Grunwald et al., 
1984). 
It would be interesting to establish whether retinal autoregulation is impaired in 
sickle cell patients; either reflecting retinal ischemia, or as a consequence of a more 
widespread disturbance of microvascular flow regulation. It would identify one more 
determinant of its incompletely understood clinical course and might suggest a different 
approach to future therapy. 
PATIENTS AND METHODS 
Patients registered at the Sickle Cell Clinic of the Los Angeles County Hospital were 
invited to participate in this study. The sickle cell group consisted of 10 Hb SS, 5 Hb SC 
and 3 Hb S-beta-thalassemia patients. The six healthy controls with Hb AA were age and 
sex matched. 
A complete eye examination was performed in all patients. Red-free photographs 
of the disk area were taken before and after 6 minutes of pure oxygen breathing. A Zeiss 
fundus camera was used and 100 ASA Kodak Panchromatic Film. We used a Rubin one 
way valve and a five liter rubber breathing bag to ensure the oxygen delivery. 
Changes in vessel diameter were measured by a masked observer (Joan Schwoerer, 
Tuft-New-England Medical Center, Boston). The fundus photographs were digitized on a 
monitor, after which a best fit circle was superimposed on the disk margin and a concentric 
circle of twice the optic disc radius was traced. Operator-assisted measurements of vessel 
segments started at the intersection of that vessel and the concentric circle, and were 
performed over a lenghth of 20 pixels. Vessel edges were chosen as the points of maximum 
density gradient on the density gradient profile across the edge. The shortest distance 
between the two edges from each of the initial twenty pixels on the first edge were 
calculated and averaged. Measurement of each vessel was performed three times. Repeat 
measurements included retracing the best-fit circle on the optic disk margin. The vessel 
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constriction was expressed as a percentage of the initial vessel diameter. In each eye we 
compared the superior and inferior temporal vein and artery before and after oxygen 
administration. 
The differences in vessel constriction between sickle cell patients and controls were tested 
for statistical significance by including these measurements as dependent variables in a 
repeated measurements analysis of variance (ANOVA). Because of missing data a 
maximum likelyhood estimation method was used in the ANOVA (program 5V of BMDP). 
The between-patient factor (i.e. the presence or absence of Hb S) was the grouping factor 
with two levels. There were four repeated measurements of the dependent variable 
generated by two within-patient factors, each with twolevels: left or right eye and pre-post 
breathing. Moreover, a constant covariable (i.e. age) was available. We considered a P-
value of less than 0.05 as significant. 
RESULTS 
One of the Hb SS and one of the Hb SC patients had peripheral retinal neovascularisation 
over less than 20% degrees. 
Only for the measurements of the superior and inferior temporal arteries and veins 
sufficient data were available for statistical analysis. The three consecutive measurements 
of each vessel width were strongly intercorrelated (all correlations > 0.95). All changes 
were statistically significant decrements. 
Only vasoconstriction of the superior temporal artery showed a statistically 
significant impairment in the sickle cell patient group (Table 33). Numbers were too small 
for seperate analysis of Hb SS, Hb SC, or Hb Sthal, or the presence of proliferative 
retinopathy. 
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105 
COMMENT 
Microvascular flow regulation is effected by the autonomic nervous system, by 
autoregulation, or both (Renkin 1984). Because there is no autonomous nerve supply in the 
retina (Aim et al., 1973; Bill, 1984), autoregulation alone accounts for flow regulation. 
As differences in retinal flow are not directly measurable in humans, indirect 
measurements of varying sensitivity are used: -flow-velocity of characteristically the 
arterioles with laser Doppler velocimetry (Gninwald et al., 1986) or the perifoveal 
capillaries using the entoptic phenomenon (Sinclair et al., 1982), -cinematography of a 
fluoresceine bolus (Ffytge et al., 1974) - and by measuring change in vessel diameter 
(greater diameter associated with greater flow)(Sieker et al., 1953; Stefansson et al., 1986). 
Vessel diameter changes have traditionally been performed by comparing calliper 
measurements from projected slides (Sieker et al, 1953; Hickam et al., 1960; Stefansson et 
al., 1986). This method has two disadvantages - i.e. exact determination of the vessel 
border (particularly at the screen magnification used) is hazardous, just as ensuring exact 
matching sites for comparison is. Both difficulties are best overcome by morphometric 
measurements performed by a computer program in which a preset difference in contrast 
marks a vessel wall, and care is taken to ensure that the same sites are compared. 
Furthermore, by comparing stretches of vessel and averaging width, we were able to further 
minimise comparison error. 
Retinal autoregulation probably serves to ensure a constant level of oxygen supply. 
It occurs after a variety of stimuli: the breathing of pure oxygen (decrease of flow)(Sieker 
et al., 1953), lowering of perfusion pressure by raising intraocular pressure (increase in flow 
over a limited range of pressure rise)(Riva et al., 1982) and dark adaptation (increase in 
flow)(Riva et al., 1983). Autoregulation decreases in older people, in hypertensive or 
atherosclerotic patients, and in diabetics, particularly in those with proliferative retinopathy 
associated with areas of non-perfused and ischemic retina. Interestingly, the impairment of 
vasoconstriction after oxygen breathing proved reversable after panretinal laser 
coagulation, which has been shown to raise the oxygen levels over treated areas (Grunwald 
et al., 1986). These observations in diabetics may indicate that the impairment of 
autoregulation is related to the extent of retinal ischemia. 
Three not mutually exclusive mechanisms are thought to regulate vessel contraction 
in autoregulation: metabolic pathways, muscle stretch and tissue pressure. Under 
physiologic circumstances the first two are operative (Johnson, 1964,; Renkin, 1984). 
Smooth muscle cells of the larger arterioles are the major effector cells in autoregulation 
(Renkin, 1986). Endothelial cells play a modulating role (Vanhoutte et al., 1986), whereas 
pericytes may have an effector role in the capillaries (Frank, 1986). 
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The impairment of retinal autoregulation in sickle cell patients we found, may be 
caused by mechanical (due to erythrocyte plugs) or ischemic damage (during vaso-occlusive 
episodes) to the endothelium and pericytes. The impairment of retinal auto-regulation may 
be correlated with the extent of retinal ischemia, just as in diabetics. 
Despite the low sensitivity of the method used by us (40% as compared to Laser 
Doppler velocimetry)(Grunwald et al., 1986), we found that retinal autoregulation of the 
sickle cell patients we tested was impaired. It would be interesting to test retinal 
autoregulation in a greater number of patients, to analyse factors like different 
hemoglobins, extent of retinal ischemiia, and both untreated and treated proliferative 
sickle cell retinopathy. However, our finding draws attention to a yet not well known factor 
in sickle cell disease: microvascular control. 
107 
APPENDIX A: OCULAR FINDINGS IN SICKLE CELL PATIENTS 
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DOS 
нь 
сошла 
sngold 
tort/SP/IS 
BS 
CO 
Grl,II,III,IV,V 
FAG 
snail 
hole,tear 
cellophane 
Sex 
К 
95 
96 
97 
98 
99 
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106 
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110 
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116 
117 
IIB 
119 
120 
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Ε M 
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Ε H 
F M 
I H 
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Τ M 
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J Η 
R M 
L И 
V H 
L H 
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G M-R 
Τ M 
S N 
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A N 
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D N 
В О 
G Ρ 
U Ρ 
H Ρ 
Ε Ρ 
S Ρ 
Α Ρ 
Ε Ρ 
Ρ Ρ 
J Ρ 
Ν Ρ 
- : not performed ( or 
visualised ) 
date of birth + : present or performed 
hemoglobin type 0 : absent or zero 
conjunctival sign 
angoid streaks 
tortuosity/salmon patches/iridescent spots * in ruitere 
black sunbursts - in пшЬегв 
mild or moderate in Condon's classification 
stages I,II,III,IV and V in Goldberg's classification 
- in degrees of circunpherencfal involvement 
fluorescein angiogram 
snail treck peripheral degeneration 
retinal hole,retinal tear 
white without pressure peripheral alterations 
cellophane maculopathy 
Age Hb V00VOS Cornile Vltr Ango Tort/SP/IS BS Co St I degrGr II degGrllld Gr IGr V 
200340 SF 
100360 SC 
180646 SC 
100666 SC 
210464 SC 
91271 SC 
200544 SC 
230251 SC 
230330 SF 
200926 SC 
140151 SC 
230859 SC 
121257 SS 
51059 SS 
141264 SS 
100701 SC 
281257 SC 
240914 SS 
90581 SC 
170363 SS 
80663 SC 
151155 SC 
250852 SS 
130845 SS 
250946 SC 
80264 SS 
200936 SC 
100647 SC 
10280 SS 
41243 SC 
40477 SS 
200976 SS 
100626 SS 
20540 SS 
270646 SS 
180364 SC 
100466 SC 
150945 SC 
220450 SC 
41267 SS 
170937 SS 
100671 SS 
60486 SS 
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0 
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- : not performed ( or 
visualised ) 
DOB : date of birth + : present or performed 
Hb : hemoglobin type 0 : absent or zero 
coma : conjwctival sign 
angoid : angoid streaks 
tort/SP/IS : tortuosity/salmon patches/iridescent spots - in nunbers 
BS black sunbursts - in nunbers 
Co : mild or moderate in Condon's classification 
GrI,II,IIl,IW,V : stages I,II,III,IV and V in Goldberg's classification 
- in degrees of circunpherencial involvement 
FAG : fluorescein angiogram 
snail : snailtrack peripheral degeneration 
hole,tear : retinal hole,retinal tear 
wup : uh ite without pressure peripheral alterations 
cellophane : cellophane maculopathy 
Sex Age Hb VODVOS Corma Vitr Ango Tort/SP/IS BS Co St I degrGr II degCrllld Gr I 
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160 
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Hb 
Саши 
Tort/SP/IS 
BS 
Co 
СП 
+ 
η 
s 
d 
wwp 
snail 
hole 
OCULAR FINDINGS IN CONTROLS UITH KB AS ANO HB AA. 
: hemoglobin type 
: conjunctival sign 
: tortuosity/salmon patch/iridescent spots ( in mmbers ) 
: black sinburst (in nmfcers) 
: mild to moderate peripheral retinal changes in Condon's 
Classification 
: grade I in Goldberg's classification 
: present 
: normal 
: syneresis 
: posterior vitreous detachment 
: "white without pressure" peripheral retinal alteration 
: "snailtraclc" peripheral retinal degeneration 
: round peripheral retinal hole 
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21 
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23 
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SUMMARY 
From November 1986 through June 1988 we examined 81 Hb SS, 97 Hb SC, 8 Hb SF and 
two Hb S-beta-thalassemia patients on Curacao, having made an effort to recruit all 
tracable patients. As these patients represent about half of the estimated number of 
patients based on genefrequency and over threequarter of previously diagnosed cases, this 
study is the most comprehensive ophthalmological survey of an entire population of sickle 
cell patients reported. 
Pathophysiology, clinical course of its major variants, diagnosis and treatment of 
sickle cell disease are briefly discussed in Part I. Intracellular polymerisation of 
deoxygenated Hemoglobin S (Hb S) renders the erythrocyt rigid and is responsable for 
vasoocclusion in the microcirculation of many organs, including the eyes. The clinical 
course is characterized by chronic hemolysis, vaso-occlusive events and a heightened 
susceptability to infection. The clinically most severe form is Hb SS disease, though blood 
rheology is also significantly impaired in another variant: Hb SC disease. However, only 
the eyes are more severely affected in Hb SC patients than in Hb SS. 
In part II a review of published ocular findings in sickle cell patients is presented. 
Differential diagnoses are mentioned briefly. Choroidal and retinal vasoocclusion, as well 
as retinal neovascularization are discussed. Involvement of almost all ocular tissues has 
been reported: the conjunctival sign, iris atrophy, secondary glaucoma and occlusion of 
choroidal vessels. Most reports concern retinal vasoocclusions. Major artery occlusions 
appear to be extremely uncommon and may be a chance correlation only; however, smaller 
vessel occlusions and capillary drop-out occur often, sometimes in the posterior pole and 
frequently in the periphery. Proliferative retinopathy, with vitreous hemorrhage and 
tractional retinal detachment as sight-threatening complications, occurs particularly in Hb 
SC disease. The place of prophylacic photocoagulation treatment is not yet well defined. 
Surgical treatment in cases of retinal detachment or persistent vitreous hemorrhage has 
proven to have specific intra- and postoperative complications. 
Part III contains results of the survey on Curacao grouped according to the involved 
region of the eye, similar to the arrangement found in Part II. Our findings are similar to 
those of previously published reports regarding the occurrence of the conjunctival sign, iris 
atrophy, angoid streaks and the sequelae of retinal hemorrhage i.e. black sunbursts, 
iridescent spots and salmonpatches. Casuistic evidence of an increased risk of disk damage 
in Hb AS cases with traumatic hyphema is presented. We found no major vessel occlusions 
and found in only one case the involvement of a smaller vessel in the posterior pole. 
Proliferative sickle retinopathy was found in 70% of the Hb SC patients over 20 years of 
age. Proliferative sickle retinopathy proved to be the main sickle cell disease related cause 
of severe visual loss in one eye in this population: 6 eyes. One Hb SS patient suffered 
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bilateral cortical blindness due to postoperative circulatory shock and apnea following a 
cholecystectomy. Due to the aselective nature of our survey the frequency of severe visual 
loss (2% in Hb SS and 6% in Hb SC patients) is lower than that indicated in other reports. 
Insufficient follow-up and small numbers would invalidate any conclusions that might be 
drawn from our prophylactic treatment results. 
Part IV contains some results from our survey that had not been previously adressed 
in the literature. 
We found that synchysis and total posterior vitreous detachment occured 
significantly more often in proliferative retinopathy, which probably represents a secondary 
phenomenon. Due to the lack of longitudonal observations, we can only speculate on a 
causative role of the vitreous in complications like vitreous hemorrhage and retinal 
detachment. 
Although we originally felt that choriocapillaris filling might be impaired in sickle 
cell patients, it was later learned, however, that the same patchy filling patterns occurred in 
matched controls. 
We found that statistically significant larger areas of nonperfused retina occurred 
both in Hb SC patients as compared to Hb SS patients, and, within the Hb SC group, in 
patients with proliferative retinopathy. This suggests that, as is the case in diabetes 
mellitus, the extent of ischemic retina may influence the amount of neovascularization, by 
the production of factors with a net angiogenic stimulus. 
Compared to controls, retinal vascular autoregulation, as measured by 
vasoconstriction after the beathing of pure oxygen, proved to be significantly impaired in a 
group of sickle cell patients in Los Angeles. This finding draws attention to a not yet well 
known factor in the pathophysiology of sickle cell disease, i.e. microvascular control. 
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SAMENVATTING 
In de periode van November 1986 tot July 1988 hebben wij 81 Hb SC, 97 Hb SC, 8 Hb SF 
en 2 Hb S-beta-thalassemie patiënten op Curacao onderzocht, waarbij wij veel moeite 
hebben gedaan zo veel mogelijk van deze patiënten op te sporen. Omdat het aantal 
onderzochte patiënten ongeveer de helft van het op grond van genfrequentie te verwachten 
aantal sikkelcel patiënten is, en meer dan driekwart van de ooit geregistreerde sikkelcel 
patiënten, is deze studie waarschijnlijk het volledigste oogheelkundige onderzoek van een 
gehele populatie sikkelcelpatienten. 
De pathophysiologie, de kliniek van de belangrijkste genotypen, de diagnose en de 
behandeling van sikkelcel ziekte worden in Deel I kort besproken. Intracellulaire 
polimerisatie van gedesoxygeneerd Hemoglobine S (Hb S) veroorzaakt rigiditeit van de 
erythrocyt en daardoor vaso-occlusie in de microcirculatie van vele organen, de ogen niet 
uitgezonderd. Het klinisch beloop wordt gekenmerkt door een chronische hémolyse, 
pijnaanvallen door vaso-occlusie in diverse organen, en een verhoogte vatbaarheid voor 
infecties. Homozygote sikkelcel anemie (Hb SS) is klinisch de ernstigste vorm, hoewel ook 
bij patiënten, die dubbel heterozygoot zijn voor Hb S en Hb С (Hb SC) de bloed rhéologie 
gestoord is. Desondanks zijn alleen de oogafwijkingen bij Hb SC patiënten ernstiger dan bij 
Hb SS patiënten. 
Deel II bevat een literatuuroverzicht van de oogheelkundige afwijkingen bij 
sikkelcel patiënten. Tevens worden de differentiaal diagnosen genoemd, en de 
pathophysiologie van retinale vaatocclusie en neovascularisatie besproken. Van bijna alle 
structuren in het oog zijn er afwijkingen beschreven: conjunctivale vaatocclusies, secundair 
glaucoom, iris atrophie, angioide strepen, en occlusies van de chorioidale vaten. De meeste 
publicaties behandelen retinale vaatocclusies. Occlusie van de grotere arterieen zijn uiterst 
zeldzaam, en komen mogelijk niet significant frequenter voor dan bij met-sikkelaars. 
Occlusies van kleinere vaten, en capillaire uitval komen frequent voor, soms in de 
achterpool, veelvuldig in de perifere retina. Proliferatieve retinopathie, met als 
visusbedreigende complicaties glasvochtbloedingen en gecombineerde 
tractie/rhegmatogene ablatio retinae, komt vooral voor bij Hb SC patiënten. De plaats van 
prophylactische lasercoagulatie is nog niet geheel duidelijk en wordt hopelijk opgeheldert 
door een thans lopend prospectief en gerandomiseerd onderzoek. Zowel conventionele 
ablatio chirurgie als vitrectomie blijken specifieke per- en postoperatieve complicaties te 
hebben. 
In deel ΙΠ worden de resultaten van het onderzoek op Curacao gepresenteerd in de 
volgorde van deel II, per aangedaan deel van het oog. Onze bevindingen aangaande het 
voorkomen van de conjunctiva afwijkingen, iris atrophie, angioide strepen en de gevolgen 
van retinale vaatocclusies, zoals "black sunbursts", "glinsterende kristallen" en " salmon 
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patches" verschillen niet met de eerder gepubliceerde gegevens in de literatuur. We 
bespreken casuïstiek over ernstig verlopend glaucoom na traumatisch hyphema bij 
patiënten met Hb AS. Wij vonden geen occlusies van grote retina vaten, en slechts een 
geval van arteriolaire occlusie in de achterpool. Bij 70% van de Hb SC patiënten ouder dan 
twintig jaar bleek er proliferatieve retinopathie voor te komen. Proliferatieve retinopathie 
was de voornaamste oorzaak van ernstig visusverlies aan een oog, dat aan sikkelcel ziekte 
te wijten was: 6%. Een Hb SS patient had corticale blindheid ten gevolge van langdurige 
hypotensie na een cholecystectomie. Doordat ons onderzoek aselectief was is de door ons 
gevonden frequentie van ernstig, door sikkelcelziekte veroorzaakt, visusverlies in een oog 
(2% bij Hb SS- en 6% bij Hb SC patiënten) lager dan in de literatuur. Door gebrekkige 
nacontrole en het kleine aantal laten de resultaten van onze eigen prophylactische 
laserbehandeling geen conclusies toe. 
Deel IV bevat enige resultaten, die nog niet in de literatuur besproken waren. 
Synchysis en achterste glasvochtloslating kwamen significant vaker voor bij 
proliferatieve retinopathie, wat waarschijnlijk een gevolg is van verhoogte 
vaatpermeabiliteit bij sikkelcel patiënten, met name in de aanwezigheid van proliferatieve 
retinopathie. Bij complicaties als glasvochtbloedingen en ablatio retinae zou de achterste 
glasvochtloslating wel een causale rol kunnen spelen. 
Hoewel wij verwachtten, dat de vulling van de choriocapillaris gestoord zou zijn bij 
sikkelcel patiënten, bleken de zelfde vullingspatronen bij "matched" controles te zien te 
zijn. 
We vonden, dat de gebieden met niet-geperfundeerde retina significant groter 
waren zowel bij Hb SC patiënten vergeleken met de Hb SS patiënten, als, in de Hb SC 
groep, bij de patiënten met proliferatieve retinopathie vergeleken met patiënten zonder 
proliferatieve retinopathie. Dit suggereert dat, net als bij diabetici, de uitgestrektheid van 
ischemische retina de hoeveelheid neovascularisatie beïnvloedt, door de productie van 
factoren te produceren met een netto angiogenesis stimulerend effect. 
Vergeleken met controles bleek de retinale autoregulatie, gemeten als de 
vasoconstrictie na puur zuurstof ademen, significant verminderd in een groep sikkelcel 
patiënten in Los Angeles. Deze bevinding vestigt de aandacht op een nog niet goed 
bekende factor in de pathophysiologie van sikkelcel ziekte: microvasculaire controle. 
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RESUMEN 
Den e periodo di november 1986 te ku yuni 1988 nos a eksamina oftalmologikamente na 
Korsou un total di 81 pashent ku Hb SS, 97 ku Hb SC, ocho ku Hb SF i dos cu Hb S-beta-
talasemia. Nos a basi nos maksimo esfuerso pa hana mas tantu di e tipo di e pashentnan 
aki posibel. Turnando e kantidat di pashent ku nos a eksamina na konsiderashon (e 
kantidat aki ta representa mas o menos mitar di e totalidat di pashentnan ku sekelsel, 
kalkula a base di insidensia di e geno en kestion), i tambe e hecho ku e kantidat aki ta 
representa mas ku tres kuatra parti di tur pashent registra komo tal, nos por bisa ku nos 
estudio ku tur probabilidat ta investigashon oftalmologiko mas kompletu ku te ainda a 
wordu réalisa den un population di pashent ku ta sufrí di enfermedat di sekelsel. 
Den e prome parti di e estudio aki ta trata patofîsiologia, e aspektonan kliniko di e typonan 
mas importante di sekelsel, diagnosis i tratamentu di e enfermedat en kestion. 
Polimerisashon intraselular di hemoglobin S (Hb S) desoksigena ta pone eritrositanan bira 
steif i asina sera e ardunan mas chiki den e differente organo, inkluso den wowo. E kurso 
kliniko di e enfermedat aki ta karakterisa pa un anemi hemolitika kroniko, atakenan di 
dolo kausa pa oklushon di ardu den differente organo i tendentia pa hana infekshon 
relativamente frekwente. Anemia di sekelsel homozygota (Hb SS) ta e forma mas grave di 
sekelsel, anke seka e patientnan ku ta heterozygota pa Hb S i Hb С (Hb SC) tambe 
reologia di sanger ta defisiente. Seka pashentnan ku Hb SC problemanan ku wowo ta mas 
serio ku seka pashent ku Hb SS. 
E di dos parti di nos estudio ta kontene resumen di literatura tokante defekto di 
wowo seka pashent ku ta sufri di enfermedat di sekelsel. Tambe ta diskuti diagnosis 
diferensial i patofîsiologia di oklushon di ardu i formashon di ardunan nobo den retina di 
wowo. Aberashonnan den kasi tur parti di wowo ta wordu deskribi, manera por ehempel 
oklushon di ardunan den konyunktiva, gloukoma sekundario, atrofia di iris, angioid streaks, 
i oklushon di ardunan di koroidea. Mayoría di e publikashonan ta trata oklushon di ardu 
den retina. Insidenti di oklushon di ardunan mas grandi ta parse di ta masha abou i 
probablemente no ta diferensia di esun seka personanan ku no ta sufri di e enfermedat 
sekelsel. Oklushon di ardunan mas chiki i di asina yama kapilernan, de bes en kuendo den 
e parti sentrai di retina, pero mas frekwente den e parti periferio, si ta mas komun. 
Retinopatia proliferata, ku tin komo komplikashon ku e por afekta bista di e pashent 
kousando sangrementu den vitreo о ku e retina ta laga los, ta manifesta su mes 
espesialmente seka pashent ku Hb SC. Ainda balor di tratamentu profilaktiko ku 
laserkoagulashon no ta sigur.Ta di spera ku lo bin klaridat riba e asunto aki den un estudio 
prospektivo i randomisa ku ta turnando luga awor. E terapia kirurgiko konvenshonal di 
retina ku a los i vitrektomia pa sangrementu den vitreo por kousa komplikashon tanto 
durante komo después di operation. 
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Den e di tres parti di e estudio aki nos ta presenta resultadonan di e investigashon 
basi na Korsou. Nos ta sigui e mesun klasifïkashon según e parti di wowo ku ta afekta, ku a 
busa den e di dos parti di e estudio aki. E loke nos a enkontra den nos estudio, pa loke ta 
trata insidensia di defekto di conyunktiva, atrofia di iris, angioid streaks i efektonan di 
oklushon di ardu chiki di retina, manera "black sunbursts", "iridescent spots" i "salmon 
patches", non ta diferensia di lokual ta wordu deskribi den literatura riba e topiko aki. Nos 
ta presenta algún kaso di un gloukoma di un indole grave ku a desaroya seka aigu 
patientnan ku Hb AS despues hifema a konsekuentia di trauma. Nos no a topa niun kaso di 
oklushon di ardunan grandi den retina i solamente un caso di okklusi arteriolar den e parti 
sentrai di retina. Nos a hana retinopatia proliferata seka 70% di e pashentnan ku Hb SC 
riba binti ana di edat. E retinopatia proliferata aki tabata e kausa prinsipal di perdida di 
bista a konsekuensia di enfermedat di sekelsel: seis di nos pashentnan a perde bista na un 
wowo. Un patient ku Hb SS a perde su bista (siegudat kortikal) pa motibu di un shok 
sirkulatono despues di a opera halblas. Komo nos estudio a ser effektua riba base aselekto, 
e insidensia di perdida di bista ku nos a hana (2% seka pashent ku Hb SS, 6% seka pashent 
ku Hb SC) ta menos ku ta wordu deskribi den literatura. Pa motibu ku no a logra effektua 
un kontrol adekua después di tratamentu i pa motibu di e kandidat limita di pashent, no 
por saka niun konklushon tokante resultado di e terapia profilaktiko ku rayo laser ku nos a 
instituí. 
E di kuater parti di e estudio ta kontene algún resultado, ku nos no a hana den 
literatura riba e topika aki. 
A sali na kla ku e insidensia de synchysis i despego di vitreo di atrás ta 
signifikamente mas haltu den kasonan ku retinopatia proliferata; probablemente esaki ta 
wordu kousa pa un permeabilidat eleva den e ardunan seka pashent ku ta sufrí di e 
enfermedat sekelsel. Ta bien posibel ku despego di vitreo ta kousa di komplikashionnan 
manera sangrementu den e vitreo o despego di retina. 
Anke na inisio nos tabata kere ku yenamentu di choriocapillaris lo munstra defekto, 
nos investigashon a munstra ku esaki no ta diferensia di lokual nos a hana den nos grupo di 
kontrol. 
Nos a deskubri ku e partinan di retina kaminda no tin perfushon di sanger, ta 
signifikativamente mas grandi seka pashent ku Hb SC kompara ku seka pashent ku Hb SS, 
mientras den e grupo di pashent ku Hb SC mes esaki tambe ta konta pa esnan ku 
retinopatia proliferata. Ta parse ku, meskos ku ta e kaso seka hende ku ta sufrí di suku, 
grandura di area di e retina iskemiko ta influensia intensidat di formashon di ardunan 
nobo, produshiendo faktornan ku efeto neto di angiogenesis. 
Den un grupo di pashent ku ta sufrí di e enfermedat sekelsel na Los Angeles, 
outoregulashon di retina, midi komo e vasokonstrikshon después di konsumo di oxygeno 
puro, tabata signifikativamente menos kompara ku loke a hana den un grupo di kontrol. E 
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asunto aki ta hala nos attenshon riba un faktor, ku ainda no a keda studia adekuademente 
den patofisiologia di enfermedat di sekelsel: kontrol mikrovaskular. 
CURRICULUM ГГАЕ 
Johan Casper van Meurs was born in Amsterdam on July 30,1954. After obtaining his 
secondary school certificate in 1972 (Gymnassium beta, Nederlands Lyceum, Den Haag), 
he enrolled to study Medicine, first in Leuven, Belgium, then in Leiden, Holland, in 1973. 
In 1975 he traveled to Indonesia (Tentena, Sulawesi) for practical work (Dr. H. Wibowo), 
just as in 1979 to Yogyakarta, at the Gajah Mada University (head: Dr. Gunawan), for a 
clerkship in Ophthalmology. After graduating in 1980, he was enlisted and served as a 
Medical Officer in the Dutch Batallion in Libanon (UNIFIL) during 1981. Afterwards, he 
worked as a resident in Medicine (head: Dr. J. Roos) at the "Rode Kruis Ziekenhuis" in 
Den Haag for half a year. From 1982 to 1986 he was trained in Ophthalmology at the 
Institute of Ophthalmology in Nijmegen (head: prof. A.F. Deutman). From 1986 to 1988 he 
worked as a government ophthalmologist on the island of Curacao. From August 1988 to 
May 1989 he was a research fellow at the Doheny Eye Institute in Los Angeles (head: prof. 
S J . Ryan). At the present time he is at the Eye Hospital in Rotterdam, specializing in 
vitreoretinal surgery. 



STELLINGEN 
behorend bij het proefschrift "Ocular findings in sickle cell disease on Curacao" 
van J.C. van Meurs. 
1. Net als bij diabetici, moeten huisarts, internist en oogarts proberen periodiek 
nauwkeurig oogheelkundig onderzoek te laten verrichten bij Hb SC patiënten boven de 
achttien jaar. 
2. Bij een negroide patient met een traumatisch hyphema behoort een sikkelcel test 
te worden verricht. 
3. Bij volwassen Hb SC patiënten zijn de niet-geperfundeerde perifere retina 
gebieden uitgebreider dan bij Hb SS patiënten van vergelijkbare leeftijd, hetgeen een 
verklaring is voor het frequentere voorkomen van retinale neovascularisatie bij deze Hb 
SC patiënten. 
4. Retinale autoregulatie is gestoord bij sikkelcel patiënten. 
5. Waarschijnlijk zal over meerdere zittingen verdeelde, uigebreide scatter 
lasercoagulatie de frequentie van glasvocht bloedingen en netvliesloslatingen bij 
proliferatieve sikkel retinopathie doen afnemen. 
6. Zonder het gebruik van een nauwkeurige techniek, zoals een magnetische roerder, 
automatiche pipet, en het 'Ъаскіоааеп" van spuiten met een minimale dode ruimte, kunnen 
conclusies gebaseerd op uitslagen, die afhankelijk zijn van quantitatieve toediening van 
celsuspensies, onjuist zijn (in "Clearance rate of macrophages from the vitreous", van 
Meurs JC, et al., submitted to Curr Eye Res 1990). 
7. Bij succesvolle focale lasercoagulatie van diabetische maculopathie, gericht op 
oppervlakkige retinale lekpunten, blijkt er histopathologisch alleen in de buitenste 
nucleaire laag en dieper een lasereffect te zijn (Rutledge et al., IOVS 1990; 31: 343). 
8. Eerst na het uiterst nauwgezet verwijderen van epiretinaal weefsel kan retinotomie 
overwegen worden (in "Silicone oil in vitreoretinal surgery", Zivojnovic R, blz. 164,1987). 
9. De vele goede soldaten en heldhaftige figuren, die hij de eer heeft te kennen, 
hebben hun wapenfeiten verricht met een - of ondanks een - duidelijk gevoel van angst, 
met een aantal begeleidende verschijnselen en met een helder inzicht in de consequenties 
van hun daden (in "Over de gevechtsuitputting", van Meurs AJ, blz. 60, Rotterdam, 1955). 
10. Wie verkiest voor zijn vervoer van Engelse voertuigen afhankelijk te zijn, wordt 
noodgedwongen een bruikbare monteur. 
11. De invloed van airco's op het studeren in een tropisch klimaat is vergelijkbaar met 
de rol van een tekstverwerker bij het schrijven van een proefschrift zonder secretaresse. 
12. Pas als een na laatste plaats in Nederland kreeg Rotterdam haar Universiteit; een 
vierhonderd meter ijsbaan heeft de stad dan ook nog niet. 
Receptie na afloop van de verdediging van het proefschrift in hetzelfde gebouw: de 
(nieuwe) Aula-Congresgebouw van de Katholieke Universiteit, Comeniuslaan 2, Nijmegen. 
Bij het Radbout Ziekenhuis, direct naast het Tandheelkunde gebouw aan de Sint 
Annastraat. 


